Estradiol
(VOXZDWNPVJITMN-ZBRFXRBCSA-N)
Structure
- SMILES
- Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2O)C
- Type(s)
- Approved; Investigational; Vet_approved
- ATC code(s)
- G02BB01; G03AA14; G03AA17; G03AB08; G03CA03; G03CA53; G03EA01; G03EA02; G03EA03; G03FA01; G03FA02; G03FA03; G03FA04; G03FA05; G03FA06; G03FA07; G03FA08; G03FA09; G03FA10; G03FA11; G03FA12; G03FA13; G03FA14; G03FA15; G03FA16; G03FA17; G03FB01; G03FB02; G03FB03; G03FB04; G03FB05; G03FB06; G03FB07; G03FB08; G03FB09; G03FB10; G03FB11; G03FB12; G03HB01
- Molecular Formula:
- C18H24O2
- Molecular Weight:
- 272.382
- Log P:
- 3.6092
- Hydrogen Bond Acceptor:
- 2
- Hydrogen Bond Donor:
- 2
- TPSA:
- 40.46
- CAS Number(s):
- 50-28-2; 73459-61-7
Synonym(s)
1.
Estradiol
2.
17 beta-Estradiol
3.
Estradiol-17 beta
4.
Oestradiol
5.
17 beta-Oestradiol
6.
Aerodiol
7.
Delestrogen
8.
Estrace
9.
Estraderm TTS
10.
Estradiol Anhydrous
11.
Estradiol Hemihydrate
12.
Estradiol Hemihydrate, (17 alpha)-Isomer
13.
Estradiol Monohydrate
14.
Estradiol Valerate
15.
Estradiol Valeriante
16.
Estradiol, (+-)-Isomer
17.
Estradiol, (-)-Isomer
18.
Estradiol, (16 alpha,17 alpha)-Isomer
19.
Estradiol, (16 alpha,17 beta)-Isomer
20.
Estradiol, (17-alpha)-Isomer
21.
Estradiol, (8 alpha,17 beta)-(+-)-Isomer
22.
Estradiol, (8 alpha,17 beta)-Isomer
23.
Estradiol, (9 beta,17 alpha)-Isomer
24.
Estradiol, (9 beta,17 beta)-Isomer
25.
Estradiol, Monosodium Salt
26.
Estradiol, Sodium Salt
27.
Estradiol-17 alpha
28.
Estradiol-17beta
29.
Ovocyclin
30.
Progynon-Depot
31.
Progynova
32.
Vivelle
33.
17 beta Estradiol
34.
17 beta Oestradiol
35.
Estradiol 17 alpha
36.
Estradiol 17 beta
37.
Estradiol 17beta
38.
Progynon Depot
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 1384 Canada Vigilance: 541 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 2 | Product adhesion issue | FAERS: 1027 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 3 | Product quality issue | FAERS: 990 Canada Vigilance: 34 | Canada Vigilance OFFSIDES US FAERS | |
| 4 | No adverse event | FAERS: 623 | US FAERS | |
| 5 | Headache | FAERS: 404 Canada Vigilance: 126 | Canada Vigilance SIDER US FAERS | |
| 6 | Application site erythema | FAERS: 402 | SIDER US FAERS | |
| 7 | Wrong technique in product usage process | FAERS: 386 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Application site rash | FAERS: 385 | OFFSIDES SIDER US FAERS | |
| 9 | Application site pruritus | FAERS: 336 | OFFSIDES US FAERS | |
| 10 | Vulvovaginal discomfort | FAERS: 268 Canada Vigilance: 21 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 11 | Wrong technique in drug usage process | FAERS: 265 | OFFSIDES US FAERS | |
| 12 | Feeling abnormal | FAERS: 252 Canada Vigilance: 3 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 13 | Nausea | FAERS: 238 Canada Vigilance: 104 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 14 | Drug dose omission | FAERS: 232 | OFFSIDES US FAERS | |
| 15 | Drug prescribing error | FAERS: 232 | US FAERS | |
| 16 | Application site irritation | FAERS: 206 | SIDER US FAERS | |
| 17 | Pruritus | FAERS: 196 Canada Vigilance: 542 | 7866818 | CTD SIDER Canada Vigilance US FAERS |
| 18 | Malaise | FAERS: 190 Canada Vigilance: 23 | Canada Vigilance SIDER US FAERS | |
| 19 | Night sweats | FAERS: 181 Canada Vigilance: 7 | Canada Vigilance SIDER US FAERS | |
| 20 | Product use issue | FAERS: 178 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 21 | Pharmaceutical product complaint | FAERS: 170 | OFFSIDES US FAERS | |
| 22 | Dizziness | FAERS: 169 Canada Vigilance: 67 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 23 | Alopecia | FAERS: 166 Canada Vigilance: 26 | 20053802 | CTD OFFSIDES SIDER Canada Vigilance US FAERS |
| 24 | Vulvovaginal pain | FAERS: 166 Canada Vigilance: 2 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 25 | Vulvovaginal burning sensation | FAERS: 161 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 26 | Pain | FAERS: 143 Canada Vigilance: 56 | 8918680 11991445 19773532 | CTD OFFSIDES SIDER Canada Vigilance US FAERS |
| 27 | Application site pain | FAERS: 138 | OFFSIDES US FAERS | |
| 28 | Vaginal Discharge | FAERS: 138 Canada Vigilance: 18 | Canada Vigilance SIDER US FAERS | |
| 29 | Incorrect drug administration duration | FAERS: 128 | US FAERS | |
| 30 | Hypersensitivity | FAERS: 122 Canada Vigilance: 18 | Canada Vigilance SIDER US FAERS | |
| 31 | Fatigue | FAERS: 120 Canada Vigilance: 71 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 32 | Incorrect dose administered | FAERS: 119 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 33 | Anxiety | FAERS: 118 Canada Vigilance: 22 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 34 | Inappropriate schedule of drug administration | FAERS: 118 | OFFSIDES US FAERS | |
| 35 | Breast tenderness | FAERS: 110 Canada Vigilance: 65 | Canada Vigilance SIDER US FAERS | |
| 36 | Urticaria | FAERS: 103 Canada Vigilance: 28 | Canada Vigilance SIDER US FAERS | |
| 37 | Abdominal Pain | FAERS: 99 Canada Vigilance: 33 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 38 | Erythema | FAERS: 99 Canada Vigilance: 453 | Canada Vigilance SIDER US FAERS | |
| 39 | Vulvovaginal mycotic infection | FAERS: 97 Canada Vigilance: 2 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 40 | Mood swings | FAERS: 94 Canada Vigilance: 24 | Canada Vigilance SIDER US FAERS | |
| 41 | Urinary tract infection | FAERS: 93 Canada Vigilance: 5 | Canada Vigilance SIDER US FAERS | |
| 42 | Palpitations | FAERS: 92 Canada Vigilance: 33 | Canada Vigilance SIDER US FAERS | |
| 43 | Vulvovaginal dryness | FAERS: 92 Canada Vigilance: 2 | Canada Vigilance OFFSIDES US FAERS | |
| 44 | Application site reaction | FAERS: 90 Canada Vigilance: 692 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 45 | Product substitution issue | FAERS: 84 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 46 | Vulvovaginal pruritus | FAERS: 84 Canada Vigilance: 4 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 47 | Back Pain | FAERS: 82 Canada Vigilance: 23 | Canada Vigilance SIDER US FAERS | |
| 48 | Arthralgia | FAERS: 74 Canada Vigilance: 21 | Canada Vigilance SIDER US FAERS | |
| 49 | Metrorrhagia | FAERS: 74 Canada Vigilance: 18 | Canada Vigilance SIDER US FAERS | |
| 50 | Application site vesicles | FAERS: 73 | US FAERS | |
| 51 | Discomfort | FAERS: 72 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 52 | Drug administration error | FAERS: 72 | US FAERS | |
| 53 | Product physical issue | FAERS: 72 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 54 | Skin irritation | FAERS: 72 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 55 | Vomiting | FAERS: 61 Canada Vigilance: 7 | Canada Vigilance SIDER US FAERS | |
| 56 | Burning sensation | FAERS: 57 Canada Vigilance: 44 | Canada Vigilance US FAERS | |
| 57 | Application site urticaria | FAERS: 56 | US FAERS | |
| 58 | Asthenia | FAERS: 56 Canada Vigilance: 18 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 59 | Cystitis | FAERS: 54 Canada Vigilance: 2 | 19181629 | CTD SIDER Canada Vigilance US FAERS |
| 60 | Hormone level abnormal | FAERS: 54 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 61 | Nervousness | FAERS: 53 Canada Vigilance: 22 | Canada Vigilance SIDER US FAERS | |
| 62 | Product dose omission | FAERS: 52 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 63 | Drug administered at inappropriate site | FAERS: 50 | OFFSIDES US FAERS | |
| 64 | Therapy cessation | FAERS: 50 | US FAERS | |
| 65 | Crying | FAERS: 48 Canada Vigilance: 12 | Canada Vigilance OFFSIDES US FAERS | |
| 66 | Adverse event | FAERS: 46 | OFFSIDES US FAERS | |
| 67 | Emotional disorder | FAERS: 46 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 68 | Abdominal discomfort | FAERS: 45 Canada Vigilance: 10 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 69 | Application site burn | FAERS: 45 | OFFSIDES US FAERS | |
| 70 | Application site discharge | FAERS: 43 | US FAERS | |
| 71 | Infection | FAERS: 42 | SIDER US FAERS | |
| 72 | Chest Pain | FAERS: 41 Canada Vigilance: 17 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 73 | Constipation | FAERS: 40 Canada Vigilance: 7 | Canada Vigilance SIDER US FAERS | |
| 74 | Product packaging issue | FAERS: 39 | US FAERS | |
| 75 | Product use in unapproved indication | FAERS: 39 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 76 | Dry skin | FAERS: 38 Canada Vigilance: 10 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 77 | Intentional product misuse | FAERS: 38 | US FAERS | |
| 78 | Therapeutic response unexpected | FAERS: 38 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 79 | Accidental exposure to product | FAERS: 37 | US FAERS | |
| 80 | Drug effect incomplete | FAERS: 37 | US FAERS | |
| 81 | Memory impairment | FAERS: 36 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 82 | Cerebrovascular accident | FAERS: 35 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 83 | Product packaging quantity issue | FAERS: 35 | US FAERS | |
| 84 | Pulmonary Embolism | FAERS: 35 Canada Vigilance: 4 | Canada Vigilance SIDER US FAERS | |
| 85 | Application site hypersensitivity | FAERS: 33 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 86 | Drug ineffective for unapproved indication | FAERS: 33 | US FAERS | |
| 87 | Skin reaction | FAERS: 33 Canada Vigilance: 39 | Canada Vigilance US FAERS | |
| 88 | Dyspareunia | FAERS: 31 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 89 | Expired product administered | FAERS: 31 | US FAERS | |
| 90 | Intentional product use issue | FAERS: 31 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 91 | Weight decreased | FAERS: 31 Canada Vigilance: 6 | Canada Vigilance SIDER US FAERS | |
| 92 | Unevaluable event | FAERS: 30 | OFFSIDES US FAERS | |
| 93 | Application site swelling | FAERS: 29 | US FAERS | |
| 94 | Acne | FAERS: 28 Canada Vigilance: 13 | Canada Vigilance SIDER US FAERS | |
| 95 | Swelling | FAERS: 28 Canada Vigilance: 6 | Canada Vigilance SIDER US FAERS | |
| 96 | Agitation | FAERS: 27 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 97 | Flushing | FAERS: 27 Canada Vigilance: 18 | Canada Vigilance SIDER US FAERS | |
| 98 | Nipple pain | FAERS: 27 Canada Vigilance: 6 | Canada Vigilance SIDER US FAERS | |
| 99 | Depressed mood | FAERS: 26 Canada Vigilance: 1 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 100 | Overdose | FAERS: 26 | US FAERS | |
| 101 | Nasopharyngitis | FAERS: 25 | SIDER US FAERS | |
| 102 | Prescribed overdose | FAERS: 25 | OFFSIDES US FAERS | |
| 103 | Product size issue | FAERS: 25 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 104 | Stress | FAERS: 25 | OFFSIDES US FAERS | |
| 105 | Vaginal erosion | FAERS: 25 | US FAERS | |
| 106 | Visual Impairment | FAERS: 25 Canada Vigilance: 17 | Canada Vigilance SIDER US FAERS | |
| 107 | Bacterial Vaginosis | FAERS: 24 | US FAERS | |
| 108 | Contraindicated product administered | FAERS: 24 | US FAERS | |
| 109 | Rash erythematous | FAERS: 24 Canada Vigilance: 68 | Canada Vigilance SIDER US FAERS | |
| 110 | Somnolence | FAERS: 24 Canada Vigilance: 4 | Canada Vigilance SIDER US FAERS | |
| 111 | Vulvovaginal erythema | FAERS: 24 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 112 | Application site dryness | FAERS: 23 | US FAERS | |
| 113 | Asthma | FAERS: 23 Canada Vigilance: 1 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 114 | Inappropriate schedule of product administration | FAERS: 23 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 115 | Poor quality drug administered | FAERS: 23 | US FAERS | |
| 116 | Tremor | FAERS: 23 Canada Vigilance: 12 | Canada Vigilance SIDER US FAERS | |
| 117 | Application site erosion | FAERS: 22 | US FAERS | |
| 118 | Application site scar | FAERS: 22 | US FAERS | |
| 119 | Dysuria | FAERS: 22 Canada Vigilance: 1 | 10340283 | CTD OFFSIDES Canada Vigilance US FAERS |
| 120 | Thrombosis | FAERS: 22 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 121 | Amnesia | FAERS: 21 | 14643695 17152362 17369909 | CTD OFFSIDES SIDER US FAERS |
| 122 | Lethargy | FAERS: 21 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 123 | Peripheral swelling | FAERS: 21 | SIDER US FAERS | |
| 124 | Tachycardia | FAERS: 21 Canada Vigilance: 6 | Canada Vigilance SIDER US FAERS | |
| 125 | Vulvovaginal swelling | FAERS: 21 | US FAERS | |
| 126 | Accidental exposure | FAERS: 20 | US FAERS | |
| 127 | Device malfunction | FAERS: 20 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 128 | Pelvic Pain | FAERS: 20 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 129 | Dyspepsia | FAERS: 19 Canada Vigilance: 11 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 130 | Hysterectomy | FAERS: 19 | OFFSIDES US FAERS | |
| 131 | Incorrect product storage | FAERS: 19 | US FAERS | |
| 132 | Medication Error | FAERS: 19 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 133 | Myalgia | FAERS: 19 Canada Vigilance: 10 | Canada Vigilance SIDER US FAERS | |
| 134 | Myocardial Infarction | FAERS: 19 Canada Vigilance: 2 | 11907179 18806603 | CTD SIDER Canada Vigilance US FAERS |
| 135 | Poor quality sleep | FAERS: 19 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 136 | Product administered at inappropriate site | FAERS: 19 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 137 | Deep Vein Thrombosis | FAERS: 18 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 138 | Drug dispensing error | FAERS: 18 | US FAERS | |
| 139 | Angina Pectoris | FAERS: 17 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 140 | Application site inflammation | FAERS: 17 | US FAERS | |
| 141 | Application site ulcer | FAERS: 17 | OFFSIDES US FAERS | |
| 142 | Chest discomfort | FAERS: 17 Canada Vigilance: 12 | Canada Vigilance SIDER US FAERS | |
| 143 | Joint swelling | FAERS: 17 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 144 | Oropharyngeal pain | FAERS: 17 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 145 | Product complaint | FAERS: 17 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 146 | Syncope | FAERS: 17 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 147 | Application site discomfort | FAERS: 16 | US FAERS | |
| 148 | Arthritis | FAERS: 15 Canada Vigilance: 2 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 149 | Diabetes Mellitus | FAERS: 15 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 150 | Feeling jittery | FAERS: 15 | US FAERS | |
| 151 | Incorrect dose administered by device | FAERS: 15 | US FAERS | |
| 152 | Uterine Cancer | FAERS: 15 | OFFSIDES SIDER US FAERS | |
| 153 | Vertigo | FAERS: 15 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 154 | Breast Cyst | FAERS: 14 Canada Vigilance: 2 | Canada Vigilance OFFSIDES US FAERS | |
| 155 | Chills | FAERS: 14 Canada Vigilance: 6 | Canada Vigilance SIDER US FAERS | |
| 156 | Emotional distress | FAERS: 14 | OFFSIDES US FAERS | |
| 157 | Inflammation | FAERS: 14 Canada Vigilance: 10 | 30387366 | CTD SIDER Canada Vigilance US FAERS |
| 158 | Maternal exposure during pregnancy | FAERS: 14 | US FAERS | |
| 159 | Osteoporosis | FAERS: 14 Canada Vigilance: 1 | 18495116 21306167 | CTD OFFSIDES Canada Vigilance US FAERS |
| 160 | Product shape issue | FAERS: 14 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 161 | Sinusitis | FAERS: 14 | OFFSIDES SIDER US FAERS | |
| 162 | Application site exfoliation | FAERS: 13 | US FAERS | |
| 163 | Cataract | FAERS: 13 | OFFSIDES US FAERS | |
| 164 | Dermatitis | FAERS: 13 Canada Vigilance: 30 | Canada Vigilance SIDER US FAERS | |
| 165 | Menorrhagia | FAERS: 13 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 166 | Tinnitus | FAERS: 13 Canada Vigilance: 5 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 167 | Blindness | FAERS: 12 | SIDER US FAERS | |
| 168 | Blood glucose increased | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 169 | Circumstance or information capable of leading to medication error | FAERS: 12 | US FAERS | |
| 170 | Device material issue | FAERS: 12 | US FAERS | |
| 171 | Dysphonia | FAERS: 12 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 172 | Feeling Cold | FAERS: 12 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 173 | Fibromyalgia | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 174 | Flatulence | FAERS: 12 Canada Vigilance: 9 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 175 | Pneumonia | FAERS: 12 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 176 | Product formulation issue | FAERS: 12 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 177 | Product storage error | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 178 | Product use complaint | FAERS: 12 | US FAERS | |
| 179 | Blood cholesterol increased | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 180 | Device Failure | FAERS: 11 | OFFSIDES US FAERS | |
| 181 | Device use issue | FAERS: 11 | US FAERS | |
| 182 | Diplopia | FAERS: 11 | US FAERS | |
| 183 | Disability | FAERS: 11 | US FAERS | |
| 184 | Irritable Bowel Syndrome | FAERS: 11 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 185 | Malabsorption from application site | FAERS: 11 | US FAERS | |
| 186 | Mental impairment | FAERS: 11 | US FAERS | |
| 187 | Neck Pain | FAERS: 11 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 188 | Therapeutic response unexpected with drug substitution | FAERS: 11 | US FAERS | |
| 189 | Atrial Fibrillation | FAERS: 10 | US FAERS | |
| 190 | Bone pain | FAERS: 10 Canada Vigilance: 7 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 191 | Drug level decreased | FAERS: 10 | US FAERS | |
| 192 | Expulsion of medication | FAERS: 10 | US FAERS | |
| 193 | General physical health deterioration | FAERS: 10 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 194 | Limb discomfort | FAERS: 10 Canada Vigilance: 10 | Canada Vigilance OFFSIDES US FAERS | |
| 195 | Menopause | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 196 | Pre-existing condition improved | FAERS: 10 | US FAERS | |
| 197 | Product availability issue | FAERS: 10 | US FAERS | |
| 198 | Product prescribing error | FAERS: 10 | US FAERS | |
| 199 | Product solubility abnormal | FAERS: 10 | US FAERS | |
| 200 | Anger | FAERS: 9 | US FAERS | |
| 201 | Bladder pain | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 202 | Breast discomfort | FAERS: 9 | SIDER US FAERS | |
| 203 | Cardiac Flutter | FAERS: 9 | US FAERS | |
| 204 | Dementia | FAERS: 9 | SIDER US FAERS | |
| 205 | Device use error | FAERS: 9 | US FAERS | |
| 206 | Drug withdrawal syndrome | FAERS: 9 | US FAERS | |
| 207 | Eczema | FAERS: 9 Canada Vigilance: 6 | Canada Vigilance SIDER US FAERS | |
| 208 | Endometriosis | FAERS: 9 Canada Vigilance: 4 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 209 | Exposure via partner | FAERS: 9 | US FAERS | |
| 210 | Incorrect product administration duration | FAERS: 9 | US FAERS | |
| 211 | Influenza | FAERS: 9 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 212 | Laceration | FAERS: 9 | US FAERS | |
| 213 | Middle insomnia | FAERS: 9 | US FAERS | |
| 214 | Alanine Aminotransferase Increased | FAERS: 8 | SIDER US FAERS | |
| 215 | Anaphylactic shock | FAERS: 8 | SIDER US FAERS | |
| 216 | Application site scab | FAERS: 8 | US FAERS | |
| 217 | Deafness | FAERS: 8 | OFFSIDES SIDER US FAERS | |
| 218 | Genital burning sensation | FAERS: 8 | US FAERS | |
| 219 | Incorrect route of drug administration | FAERS: 8 | US FAERS | |
| 220 | Multiple Sclerosis | FAERS: 8 | US FAERS | |
| 221 | Musculoskeletal discomfort | FAERS: 8 | OFFSIDES SIDER US FAERS | |
| 222 | Musculoskeletal stiffness | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 223 | Pancreatitis | FAERS: 8 | OFFSIDES SIDER US FAERS | |
| 224 | Reaction to drug excipients | FAERS: 8 | US FAERS | |
| 225 | Retching | FAERS: 8 | US FAERS | |
| 226 | Skin lesion | FAERS: 8 | US FAERS | |
| 227 | Therapeutic product effect incomplete | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 228 | Wrong technique in device usage process | FAERS: 8 | US FAERS | |
| 229 | Abasia | FAERS: 7 | OFFSIDES US FAERS | |
| 230 | Aspartate Aminotransferase Increased | FAERS: 7 | US FAERS | |
| 231 | Blood alkaline phosphatase increased | FAERS: 7 | OFFSIDES SIDER US FAERS | |
| 232 | Bronchitis | FAERS: 7 | OFFSIDES SIDER US FAERS | |
| 233 | Chromaturia | FAERS: 7 | US FAERS | |
| 234 | Cyst | FAERS: 7 Canada Vigilance: 6 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 235 | Dehydration | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 236 | Device adhesion issue | FAERS: 7 | US FAERS | |
| 237 | Device expulsion | FAERS: 7 | US FAERS | |
| 238 | Disease recurrence | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance OFFSIDES US FAERS | |
| 239 | Disorientation | FAERS: 7 | US FAERS | |
| 240 | Drug effective for unapproved indication | FAERS: 7 | US FAERS | |
| 241 | Epistaxis | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 242 | Frustration tolerance decreased | FAERS: 7 | US FAERS | |
| 243 | Gamma-Glutamyltransferase Increased | FAERS: 7 | US FAERS | |
| 244 | Hypothyroidism | FAERS: 7 | US FAERS | |
| 245 | Incorrect dose administered by product | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 246 | Injury associated with device | FAERS: 7 | US FAERS | |
| 247 | Intentional drug misuse | FAERS: 7 | OFFSIDES US FAERS | |
| 248 | Lymphadenopathy | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 249 | Lymphoma | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 250 | Malabsorption | FAERS: 7 | US FAERS | |
| 251 | Patient dissatisfaction with treatment | FAERS: 7 | US FAERS | |
| 252 | Pharyngolaryngeal Pain | FAERS: 7 | OFFSIDES SIDER US FAERS | |
| 253 | Product physical consistency issue | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 254 | Restlessness | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 255 | Retinal Detachment | FAERS: 7 | US FAERS | |
| 256 | Skin Ulcer | FAERS: 7 | SIDER US FAERS | |
| 257 | Suicide attempt | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 258 | Urinary Incontinence | FAERS: 7 Canada Vigilance: 6 | Canada Vigilance SIDER US FAERS | |
| 259 | Activities of daily living impaired | FAERS: 6 | US FAERS | |
| 260 | Anorexia | FAERS: 6 | 6305905 | CTD US FAERS |
| 261 | Aphasia | FAERS: 6 | SIDER US FAERS | |
| 262 | Application site infection | FAERS: 6 | US FAERS | |
| 263 | Application site papules | FAERS: 6 | US FAERS | |
| 264 | Bilirubinuria | FAERS: 6 | US FAERS | |
| 265 | Bladder prolapse | FAERS: 6 | US FAERS | |
| 266 | Blood urine present | FAERS: 6 | US FAERS | |
| 267 | Bone density decreased | FAERS: 6 | US FAERS | |
| 268 | Bunion | FAERS: 6 | US FAERS | |
| 269 | Device difficult to use | FAERS: 6 | US FAERS | |
| 270 | Drug Dependence | FAERS: 6 | US FAERS | |
| 271 | Drug effect delayed | FAERS: 6 | US FAERS | |
| 272 | Dysgeusia | FAERS: 6 Canada Vigilance: 11 | Canada Vigilance SIDER US FAERS | |
| 273 | Endometrial hypertrophy | FAERS: 6 | OFFSIDES US FAERS | |
| 274 | Epilepsy | FAERS: 6 | SIDER US FAERS | |
| 275 | Erythema Nodosum | FAERS: 6 Canada Vigilance: 1 | 14740516 | CTD SIDER Canada Vigilance US FAERS |
| 276 | Extra dose administered | FAERS: 6 | US FAERS | |
| 277 | Feeling of body temperature change | FAERS: 6 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 278 | Gastritis | FAERS: 6 | SIDER US FAERS | |
| 279 | Medication residue present | FAERS: 6 | US FAERS | |
| 280 | Muscle strain | FAERS: 6 | SIDER US FAERS | |
| 281 | Musculoskeletal Pain | FAERS: 6 Canada Vigilance: 3 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 282 | Neuralgia | FAERS: 6 | US FAERS | |
| 283 | Pelvic discomfort | FAERS: 6 | US FAERS | |
| 284 | Poor quality product administered | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 285 | Premenstrual syndrome | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 286 | Therapeutic product ineffective | FAERS: 6 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 287 | Vaginal lesion | FAERS: 6 | US FAERS | |
| 288 | nervous system disorder | FAERS: 6 | SIDER US FAERS | |
| 289 | Apparent death | FAERS: 5 | US FAERS | |
| 290 | Application site warmth | FAERS: 5 | US FAERS | |
| 291 | Atrophic vulvovaginitis | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 292 | Biliary Dyskinesia | FAERS: 5 | 20337216 | CTD US FAERS |
| 293 | Bladder discomfort | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 294 | Blood triglycerides increased | FAERS: 5 | OFFSIDES US FAERS | |
| 295 | Breast engorgement | FAERS: 5 Canada Vigilance: 5 | Canada Vigilance SIDER US FAERS | |
| 296 | Chemical burn of skin | FAERS: 5 | US FAERS | |
| 297 | Chloasma | FAERS: 5 | SIDER US FAERS | |
| 298 | Cholecystitis | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 299 | Cholelithiasis | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 300 | Cold sweat | FAERS: 5 | US FAERS | |
| 301 | Dermal absorption impaired | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 302 | Device leakage | FAERS: 5 | US FAERS | |
| 303 | Endometrial Hyperplasia | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 304 | Expired drug administered | FAERS: 5 | US FAERS | |
| 305 | Impaired work ability | FAERS: 5 | US FAERS | |
| 306 | Incorrect route of product administration | FAERS: 5 | US FAERS | |
| 307 | Mastectomy | FAERS: 5 | OFFSIDES US FAERS | |
| 308 | Mastitis | FAERS: 5 | US FAERS | |
| 309 | Meningioma | FAERS: 5 | SIDER US FAERS | |
| 310 | Oropharyngeal swelling | FAERS: 5 | US FAERS | |
| 311 | Pain of skin | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 312 | Pancreatic carcinoma | FAERS: 5 | US FAERS | |
| 313 | Personality Change | FAERS: 5 | US FAERS | |
| 314 | Product administration error | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 315 | Product blister packaging issue | FAERS: 5 | US FAERS | |
| 316 | Product container issue | FAERS: 5 | US FAERS | |
| 317 | Product contamination | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 318 | Product package associated injury | FAERS: 5 | US FAERS | |
| 319 | Psoriasis | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 320 | Scab | FAERS: 5 | US FAERS | |
| 321 | Therapeutic response changed | FAERS: 5 | US FAERS | |
| 322 | Thermal burn | FAERS: 5 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 323 | Uterine Polyp | FAERS: 5 | OFFSIDES US FAERS | |
| 324 | Adnexa uteri pain | FAERS: 4 | US FAERS | |
| 325 | Ankle Fracture | FAERS: 4 | OFFSIDES US FAERS | |
| 326 | Aphonia | FAERS: 4 | OFFSIDES US FAERS | |
| 327 | Application site necrosis | FAERS: 4 | US FAERS | |
| 328 | Bladder spasm | FAERS: 4 | US FAERS | |
| 329 | Cheilitis | FAERS: 4 | US FAERS | |
| 330 | Chemical injury | FAERS: 4 | US FAERS | |
| 331 | Complication of device removal | FAERS: 4 | US FAERS | |
| 332 | Contraindicated drug administered | FAERS: 4 | US FAERS | |
| 333 | Device physical property issue | FAERS: 4 | US FAERS | |
| 334 | Drug withdrawal headache | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 335 | Dysarthria | FAERS: 4 | SIDER US FAERS | |
| 336 | Ear discomfort | FAERS: 4 | US FAERS | |
| 337 | Eye Infection | FAERS: 4 | SIDER US FAERS | |
| 338 | Gastrointestinal carcinoma | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 339 | Genital Herpes | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 340 | Genital discomfort | FAERS: 4 | US FAERS | |
| 341 | Hyperplasia | FAERS: 4 | 20337216 | CTD US FAERS |
| 342 | Hypersomnia | FAERS: 4 | US FAERS | |
| 343 | Impaired quality of life | FAERS: 4 | US FAERS | |
| 344 | Incontinence | FAERS: 4 | OFFSIDES SIDER US FAERS | |
| 345 | Initial insomnia | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 346 | Limb injury | FAERS: 4 | US FAERS | |
| 347 | Migraine with Aura | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 348 | Musculoskeletal chest pain | FAERS: 4 | OFFSIDES US FAERS | |
| 349 | Nephrolithiasis | FAERS: 4 | OFFSIDES US FAERS | |
| 350 | Nonspecific reaction | FAERS: 4 | US FAERS | |
| 351 | Osteopenia | FAERS: 4 | OFFSIDES US FAERS | |
| 352 | Physical product label issue | FAERS: 4 | US FAERS | |
| 353 | Product cleaning inadequate | FAERS: 4 | US FAERS | |
| 354 | Product dispensing error | FAERS: 4 | US FAERS | |
| 355 | Pulmonary thrombosis | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 356 | Quality of life decreased | FAERS: 4 | US FAERS | |
| 357 | Sluggishness | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 358 | Stomatitis | FAERS: 4 | US FAERS | |
| 359 | Thrombocytopenia | FAERS: 4 | US FAERS | |
| 360 | Trigeminal Neuralgia | FAERS: 4 | US FAERS | |
| 361 | Vaginal mycosis | FAERS: 4 | SIDER US FAERS | |
| 362 | Vein pain | FAERS: 4 | SIDER US FAERS | |
| 363 | Visual disturbance | FAERS: 4 | SIDER US FAERS | |
| 364 | Vulvovaginal inflammation | FAERS: 4 | US FAERS | |
| 365 | Vulvovaginal injury | FAERS: 4 | US FAERS | |
| 366 | Vulvovaginitis | FAERS: 4 | SIDER US FAERS | |
| 367 | jaundice | FAERS: 4 | SIDER US FAERS | |
| 368 | Abdominal tenderness | FAERS: 3 | US FAERS | |
| 369 | Abscess | FAERS: 3 | US FAERS | |
| 370 | Anorectal discomfort | FAERS: 3 | SIDER US FAERS | |
| 371 | Application site laceration | FAERS: 3 | US FAERS | |
| 372 | Arthropathy | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 373 | Blood blister | FAERS: 3 | US FAERS | |
| 374 | Blood copper increased | FAERS: 3 | US FAERS | |
| 375 | Blood glucose decreased | FAERS: 3 | US FAERS | |
| 376 | Bruxism | FAERS: 3 | OFFSIDES US FAERS | |
| 377 | Candidiasis | FAERS: 3 | US FAERS | |
| 378 | Cataract operation | FAERS: 3 | OFFSIDES US FAERS | |
| 379 | Cerebral Infarction | FAERS: 3 | 8638876 | CTD US FAERS |
| 380 | Cholestasis | FAERS: 3 | 22841776 | CTD US FAERS |
| 381 | Colitis | FAERS: 3 | OFFSIDES US FAERS | |
| 382 | Concomitant disease aggravated | FAERS: 3 | US FAERS | |
| 383 | Coronary Artery Disease | FAERS: 3 | 12385860 | CTD US FAERS |
| 384 | Cutis Laxa | FAERS: 3 | US FAERS | |
| 385 | Cystocele | FAERS: 3 | OFFSIDES US FAERS | |
| 386 | Device deployment issue | FAERS: 3 | US FAERS | |
| 387 | Disease Progression | FAERS: 3 | US FAERS | |
| 388 | Drug administered to patient of inappropriate age | FAERS: 3 | US FAERS | |
| 389 | Economic problem | FAERS: 3 | OFFSIDES US FAERS | |
| 390 | Embolism | FAERS: 3 | OFFSIDES SIDER US FAERS | |
| 391 | Erysipelas | FAERS: 3 | US FAERS | |
| 392 | Eye irritation | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 393 | Eye laser surgery | FAERS: 3 | US FAERS | |
| 394 | Folliculitis | FAERS: 3 | 30017638 | CTD US FAERS |
| 395 | Gangrene | FAERS: 3 | US FAERS | |
| 396 | Gastric ulcer | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 397 | Genital rash | FAERS: 3 | OFFSIDES US FAERS | |
| 398 | Glaucoma | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance OFFSIDES US FAERS | |
| 399 | Gout | FAERS: 3 | OFFSIDES US FAERS | |
| 400 | Hemiparesis | FAERS: 3 | OFFSIDES SIDER US FAERS | |
| 401 | Hirsutism | FAERS: 3 Canada Vigilance: 6 | Canada Vigilance SIDER US FAERS | |
| 402 | Hysterosalpingo-oophorectomy | FAERS: 3 | US FAERS | |
| 403 | Impaired driving ability | FAERS: 3 | OFFSIDES US FAERS | |
| 404 | Joint injury | FAERS: 3 | OFFSIDES US FAERS | |
| 405 | Lip swelling | FAERS: 3 | US FAERS | |
| 406 | Lipoatrophy | FAERS: 3 | US FAERS | |
| 407 | Livedo Reticularis | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 408 | Lower respiratory tract infection | FAERS: 3 | US FAERS | |
| 409 | Macular degeneration | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 410 | Malabsorption from administration site | FAERS: 3 | US FAERS | |
| 411 | Malnutrition | FAERS: 3 | SIDER US FAERS | |
| 412 | Mental status changes | FAERS: 3 | US FAERS | |
| 413 | Muscle tightness | FAERS: 3 | OFFSIDES US FAERS | |
| 414 | Nerve injury | FAERS: 3 | US FAERS | |
| 415 | Optic Neuritis | FAERS: 3 | SIDER US FAERS | |
| 416 | Panic Disorder | FAERS: 3 | US FAERS | |
| 417 | Petechiae | FAERS: 3 | US FAERS | |
| 418 | Precocious Puberty | FAERS: 3 | US FAERS | |
| 419 | Presyncope | FAERS: 3 | US FAERS | |
| 420 | Product lot number issue | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 421 | Product measured potency issue | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 422 | Product prescribing issue | FAERS: 3 | US FAERS | |
| 423 | Product residue present | FAERS: 3 | US FAERS | |
| 424 | Restless Legs Syndrome | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 425 | Retinal Vein Occlusion | FAERS: 3 | SIDER US FAERS | |
| 426 | Retinoschisis | FAERS: 3 | US FAERS | |
| 427 | Rheumatoid Arthritis | FAERS: 3 | US FAERS | |
| 428 | Rotator cuff syndrome | FAERS: 3 | US FAERS | |
| 429 | Secretion discharge | FAERS: 3 | US FAERS | |
| 430 | Sinus headache | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 431 | Skin Wrinkling | FAERS: 3 | US FAERS | |
| 432 | Skin cosmetic procedure | FAERS: 3 | US FAERS | |
| 433 | Sneezing | FAERS: 3 | US FAERS | |
| 434 | Spondylitis | FAERS: 3 | US FAERS | |
| 435 | Suspected counterfeit product | FAERS: 3 | US FAERS | |
| 436 | Temperature intolerance | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 437 | Therapeutic product effect decreased | FAERS: 3 Canada Vigilance: 10 | Canada Vigilance US FAERS | |
| 438 | Therapy change | FAERS: 3 | US FAERS | |
| 439 | Therapy non-responder | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 440 | Throat irritation | FAERS: 3 | US FAERS | |
| 441 | Toothache | FAERS: 3 | SIDER US FAERS | |
| 442 | Uterine Prolapse | FAERS: 3 | US FAERS | |
| 443 | VIIth nerve paralysis | FAERS: 3 | US FAERS | |
| 444 | Vaginal burning sensation | FAERS: 3 | US FAERS | |
| 445 | Vitreous Detachment | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 446 | Wheezing | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 447 | skin abrasion | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 448 | treatment failure | FAERS: 3 | US FAERS | |
| 449 | Abdominal adhesions | FAERS: 2 | US FAERS | |
| 450 | Abnormal weight gain | FAERS: 2 | US FAERS | |
| 451 | Accidental overdose | FAERS: 2 | US FAERS | |
| 452 | Administration site rash | FAERS: 2 | US FAERS | |
| 453 | Allergic reaction to excipient | FAERS: 2 | US FAERS | |
| 454 | Allergy to chemicals | FAERS: 2 | US FAERS | |
| 455 | Angioedema | FAERS: 2 | SIDER US FAERS | |
| 456 | Anosmia | FAERS: 2 | US FAERS | |
| 457 | Appendicitis | FAERS: 2 | OFFSIDES US FAERS | |
| 458 | Application site excoriation | FAERS: 2 | US FAERS | |
| 459 | Application site injury | FAERS: 2 | US FAERS | |
| 460 | Atelectasis | FAERS: 2 | US FAERS | |
| 461 | Back disorder | FAERS: 2 | OFFSIDES US FAERS | |
| 462 | Basal cell carcinoma | FAERS: 2 | OFFSIDES SIDER US FAERS | |
| 463 | Benign Neoplasm | FAERS: 2 | US FAERS | |
| 464 | Benign neoplasm of thyroid gland | FAERS: 2 | US FAERS | |
| 465 | Blood calcitonin increased | FAERS: 2 | US FAERS | |
| 466 | Blood glucose abnormal | FAERS: 2 | US FAERS | |
| 467 | Blood iron abnormal | FAERS: 2 | US FAERS | |
| 468 | Blood magnesium decreased | FAERS: 2 | US FAERS | |
| 469 | Blood potassium decreased | FAERS: 2 | US FAERS | |
| 470 | Blood prolactin increased | FAERS: 2 | US FAERS | |
| 471 | Blood thyroid stimulating hormone abnormal | FAERS: 2 | US FAERS | |
| 472 | Blood zinc decreased | FAERS: 2 | US FAERS | |
| 473 | Bowel movement irregularity | FAERS: 2 | US FAERS | |
| 474 | Bradycardia | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 475 | Breast cancer recurrent | FAERS: 2 | OFFSIDES US FAERS | |
| 476 | Breast cancer stage II | FAERS: 2 | OFFSIDES US FAERS | |
| 477 | Breast cosmetic surgery | FAERS: 2 | OFFSIDES US FAERS | |
| 478 | Breast necrosis | FAERS: 2 | OFFSIDES US FAERS | |
| 479 | Bronchospasm | FAERS: 2 | SIDER US FAERS | |
| 480 | Burning Mouth Syndrome | FAERS: 2 | US FAERS | |
| 481 | Cardiac discomfort | FAERS: 2 | US FAERS | |
| 482 | Carotid artery occlusion | FAERS: 2 | US FAERS | |
| 483 | Cerebral Thrombosis | FAERS: 2 | US FAERS | |
| 484 | Cerebral disorder | FAERS: 2 | OFFSIDES US FAERS | |
| 485 | Cerebral vasoconstriction | FAERS: 2 | US FAERS | |
| 486 | Cervical dysplasia | FAERS: 2 | US FAERS | |
| 487 | Clostridium difficile infection | FAERS: 2 | US FAERS | |
| 488 | Colorectal cancer stage I | FAERS: 2 | US FAERS | |
| 489 | Contact lens intolerance | FAERS: 2 | SIDER US FAERS | |
| 490 | Contraindicated drug prescribed | FAERS: 2 | US FAERS | |
| 491 | Contraindicated product prescribed | FAERS: 2 | US FAERS | |
| 492 | Cystitis escherichia | FAERS: 2 | US FAERS | |
| 493 | Depressed Level of Consciousness | FAERS: 2 | US FAERS | |
| 494 | Dermatitis acneiform | FAERS: 2 | US FAERS | |
| 495 | Device defective | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 496 | Device related infection | FAERS: 2 | US FAERS | |
| 497 | Diverticulitis | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 498 | Drug administered in wrong device | FAERS: 2 | US FAERS | |
| 499 | Drug exposure via breast milk | FAERS: 2 | US FAERS | |
| 500 | Drug level fluctuating | FAERS: 2 | US FAERS | |
| 501 | Drug toxicity | FAERS: 2 | US FAERS | |
| 502 | Elevated mood | FAERS: 2 | US FAERS | |
| 503 | Endometrial disorder | FAERS: 2 | OFFSIDES SIDER US FAERS | |
| 504 | Endometrial sarcoma | FAERS: 2 | US FAERS | |
| 505 | Enterocele | FAERS: 2 | US FAERS | |
| 506 | Epiploic appendagitis | FAERS: 2 | US FAERS | |
| 507 | Erectile dysfunction | FAERS: 2 | 14972507 | CTD US FAERS |
| 508 | Eructation | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 509 | Erythema Multiforme | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 510 | Exfoliative rash | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance OFFSIDES US FAERS | |
| 511 | Extraocular Muscle Paresis | FAERS: 2 | US FAERS | |
| 512 | Facial Pain | FAERS: 2 | US FAERS | |
| 513 | Facial Paresis | FAERS: 2 | US FAERS | |
| 514 | Facial paralysis | FAERS: 2 | US FAERS | |
| 515 | Flank Pain | FAERS: 2 | OFFSIDES US FAERS | |
| 516 | Formication | FAERS: 2 | OFFSIDES US FAERS | |
| 517 | Gait inability | FAERS: 2 | US FAERS | |
| 518 | Gastrointestinal Pain | FAERS: 2 | SIDER US FAERS | |
| 519 | Genital labial adhesions | FAERS: 2 | US FAERS | |
| 520 | Genital pain | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 521 | Genito-pelvic pain/penetration disorder | FAERS: 2 | US FAERS | |
| 522 | Guillain-Barre Syndrome | FAERS: 2 | US FAERS | |
| 523 | Hearing disability | FAERS: 2 | US FAERS | |
| 524 | Hepatitis | FAERS: 2 | OFFSIDES SIDER US FAERS | |
| 525 | Hyperkeratosis | FAERS: 2 | OFFSIDES US FAERS | |
| 526 | Hyperventilation | FAERS: 2 | US FAERS | |
| 527 | Hypotrichosis | FAERS: 2 | US FAERS | |
| 528 | Hypoxia | FAERS: 2 | US FAERS | |
| 529 | Illogical thinking | FAERS: 2 | US FAERS | |
| 530 | Immobile | FAERS: 2 | US FAERS | |
| 531 | Impatience | FAERS: 2 | US FAERS | |
| 532 | Incorrect drug dosage form administered | FAERS: 2 | US FAERS | |
| 533 | Intentional dose omission | FAERS: 2 | US FAERS | |
| 534 | Intestinal Obstruction | FAERS: 2 | OFFSIDES SIDER US FAERS | |
| 535 | Kayser-Fleischer ring | FAERS: 2 | US FAERS | |
| 536 | Keratitis | FAERS: 2 | US FAERS | |
| 537 | Laser Therapy | FAERS: 2 | US FAERS | |
| 538 | Leukoencephalopathy | FAERS: 2 | US FAERS | |
| 539 | Libido disorder | FAERS: 2 | US FAERS | |
| 540 | Lipoma | FAERS: 2 | US FAERS | |
| 541 | Liquid product physical issue | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 542 | Lupus-like syndrome | FAERS: 2 | US FAERS | |
| 543 | Malignant breast lump removal | FAERS: 2 | US FAERS | |
| 544 | Manufacturing issue | FAERS: 2 | US FAERS | |
| 545 | Maternal exposure before pregnancy | FAERS: 2 | US FAERS | |
| 546 | Maternal exposure during breast feeding | FAERS: 2 | US FAERS | |
| 547 | Medical device complication | FAERS: 2 | SIDER US FAERS | |
| 548 | Medical device discomfort | FAERS: 2 | US FAERS | |
| 549 | Metastasis | FAERS: 2 | US FAERS | |
| 550 | Neurodermatitis | FAERS: 2 | OFFSIDES US FAERS | |
| 551 | No adverse effect | FAERS: 2 | US FAERS | |
| 552 | Noninfective oophoritis | FAERS: 2 | US FAERS | |
| 553 | Ocular discomfort | FAERS: 2 | US FAERS | |
| 554 | Onychoclasis | FAERS: 2 | US FAERS | |
| 555 | Open wound | FAERS: 2 | US FAERS | |
| 556 | Pancreatic Cyst | FAERS: 2 | US FAERS | |
| 557 | Pancreatic steatosis | FAERS: 2 | US FAERS | |
| 558 | Patient dissatisfaction with device | FAERS: 2 | US FAERS | |
| 559 | Perineal disorder | FAERS: 2 | US FAERS | |
| 560 | Perineal ulceration | FAERS: 2 | US FAERS | |
| 561 | Peritonitis | FAERS: 2 | US FAERS | |
| 562 | Post procedural complication | FAERS: 2 | OFFSIDES US FAERS | |
| 563 | Prescribed underdose | FAERS: 2 | US FAERS | |
| 564 | Product administration interrupted | FAERS: 2 | US FAERS | |
| 565 | Product design issue | FAERS: 2 | US FAERS | |
| 566 | Product outer packaging issue | FAERS: 2 | US FAERS | |
| 567 | Product taste abnormal | FAERS: 2 | US FAERS | |
| 568 | Prolactinoma | FAERS: 2 | CTD OFFSIDES US FAERS | |
| 569 | Pseudoprecocious puberty | FAERS: 2 | US FAERS | |
| 570 | Psychiatric symptom | FAERS: 2 | US FAERS | |
| 571 | Psychotic symptom | FAERS: 2 | US FAERS | |
| 572 | Pulmonary congestion | FAERS: 2 | US FAERS | |
| 573 | Renal Cell Carcinoma | FAERS: 2 | US FAERS | |
| 574 | Respiratory Failure | FAERS: 2 | US FAERS | |
| 575 | Retinal vascular thrombosis | FAERS: 2 | SIDER US FAERS | |
| 576 | Sepsis | FAERS: 2 | US FAERS | |
| 577 | Sexual Dysfunction | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 578 | Sjogren's Syndrome | FAERS: 2 | OFFSIDES US FAERS | |
| 579 | Skin Induration | FAERS: 2 | US FAERS | |
| 580 | Small intestine carcinoma | FAERS: 2 | US FAERS | |
| 581 | Stenosis | FAERS: 2 | US FAERS | |
| 582 | Stevens-Johnson Syndrome | FAERS: 2 | OFFSIDES US FAERS | |
| 583 | Stupor | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 584 | Suppressed lactation | FAERS: 2 | US FAERS | |
| 585 | Symptom recurrence | FAERS: 2 | US FAERS | |
| 586 | Tension | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 587 | Thrombophlebitis | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 588 | Thrombotic stroke | FAERS: 2 | US FAERS | |
| 589 | Toxic Shock Syndrome | FAERS: 2 | SIDER US FAERS | |
| 590 | Toxicity to various agents | FAERS: 2 | SIDER US FAERS | |
| 591 | Toxicologic test abnormal | FAERS: 2 | US FAERS | |
| 592 | Tri-iodothyronine abnormal | FAERS: 2 | US FAERS | |
| 593 | Urethral Stenosis | FAERS: 2 | US FAERS | |
| 594 | Urethritis noninfective | FAERS: 2 | US FAERS | |
| 595 | Uterine spasm | FAERS: 2 | US FAERS | |
| 596 | Vaginal mucosal blistering | FAERS: 2 | US FAERS | |
| 597 | Vaginal pH abnormal | FAERS: 2 | US FAERS | |
| 598 | Vaginal pain | FAERS: 2 | SIDER US FAERS | |
| 599 | Vascular occlusion | FAERS: 2 | US FAERS | |
| 600 | Venous Insufficiency | FAERS: 2 | OFFSIDES US FAERS | |
| 601 | Venous Thrombosis | FAERS: 2 | US FAERS | |
| 602 | Venous valve ruptured | FAERS: 2 | US FAERS | |
| 603 | Vulvovaginal adhesion | FAERS: 2 | US FAERS | |
| 604 | White blood cell count decreased | FAERS: 2 | US FAERS | |
| 605 | Wrong drug administered | FAERS: 2 | US FAERS | |
| 606 | Xanthoma | FAERS: 2 | US FAERS | |
| 607 | furuncle | FAERS: 2 | US FAERS | |
| 608 | Abnormal withdrawal bleeding | FAERS: 1 | SIDER US FAERS | |
| 609 | Acute Coronary Syndrome | FAERS: 1 | SIDER US FAERS | |
| 610 | Administration site discharge | FAERS: 1 | US FAERS | |
| 611 | Administration site discomfort | FAERS: 1 | US FAERS | |
| 612 | Administration site erythema | FAERS: 1 | US FAERS | |
| 613 | Administration site injury | FAERS: 1 | US FAERS | |
| 614 | Administration site irritation | FAERS: 1 | US FAERS | |
| 615 | Administration site mass | FAERS: 1 | US FAERS | |
| 616 | Administration site swelling | FAERS: 1 | US FAERS | |
| 617 | Adnexa uteri cyst | FAERS: 1 | US FAERS | |
| 618 | Agoraphobia | FAERS: 1 | US FAERS | |
| 619 | Allergic sinusitis | FAERS: 1 | OFFSIDES US FAERS | |
| 620 | Alpha-1 anti-trypsin abnormal | FAERS: 1 | US FAERS | |
| 621 | Altered visual depth perception | FAERS: 1 | US FAERS | |
| 622 | Animal bite | FAERS: 1 | OFFSIDES US FAERS | |
| 623 | Antiphospholipid antibodies positive | FAERS: 1 | US FAERS | |
| 624 | Aphagia | FAERS: 1 | US FAERS | |
| 625 | Apparent life threatening event | FAERS: 1 | US FAERS | |
| 626 | Application site acne | FAERS: 1 | US FAERS | |
| 627 | Application site cellulitis | FAERS: 1 | US FAERS | |
| 628 | Application site eczema | FAERS: 1 | US FAERS | |
| 629 | Application site fissure | FAERS: 1 | US FAERS | |
| 630 | Application site mass | FAERS: 1 | US FAERS | |
| 631 | Application site perspiration | FAERS: 1 | US FAERS | |
| 632 | Autoimmune neutropenia | FAERS: 1 | US FAERS | |
| 633 | Autoimmune thyroiditis | FAERS: 1 | OFFSIDES US FAERS | |
| 634 | Autonomic nervous system imbalance | FAERS: 1 | US FAERS | |
| 635 | Bacterial vulvovaginitis | FAERS: 1 | US FAERS | |
| 636 | Balanoposthitis | FAERS: 1 | US FAERS | |
| 637 | Benign mesenteric neoplasm | FAERS: 1 | US FAERS | |
| 638 | Benign neoplasm of skin | FAERS: 1 | US FAERS | |
| 639 | Bilateral breast buds | FAERS: 1 | US FAERS | |
| 640 | Biliary cancer metastatic | FAERS: 1 | US FAERS | |
| 641 | Bipolar Disorder | FAERS: 1 | OFFSIDES US FAERS | |
| 642 | Birdshot Chorioretinopathy | FAERS: 1 | US FAERS | |
| 643 | Bladder dysfunction | FAERS: 1 | US FAERS | |
| 644 | Blood Corticotrophin Decreased | FAERS: 1 | US FAERS | |
| 645 | Blood cholesterol abnormal | FAERS: 1 | OFFSIDES US FAERS | |
| 646 | Blood count abnormal | FAERS: 1 | US FAERS | |
| 647 | Blood follicle stimulating hormone decreased | FAERS: 1 | US FAERS | |
| 648 | Blood follicle stimulating hormone increased | FAERS: 1 | OFFSIDES US FAERS | |
| 649 | Blood glucose fluctuation | FAERS: 1 | US FAERS | |
| 650 | Blood immunoglobulin E decreased | FAERS: 1 | US FAERS | |
| 651 | Blood immunoglobulin G decreased | FAERS: 1 | US FAERS | |
| 652 | Blood iron increased | FAERS: 1 | US FAERS | |
| 653 | Blood lactate dehydrogenase increased | FAERS: 1 | US FAERS | |
| 654 | Blood pressure fluctuation | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 655 | Blood testosterone decreased | FAERS: 1 | US FAERS | |
| 656 | Blood thyroid stimulating hormone decreased | FAERS: 1 | US FAERS | |
| 657 | Bone fragmentation | FAERS: 1 | US FAERS | |
| 658 | Bradyphrenia | FAERS: 1 | SIDER US FAERS | |
| 659 | Breast Microcalcification | FAERS: 1 | OFFSIDES US FAERS | |
| 660 | Breast cancer stage III | FAERS: 1 | US FAERS | |
| 661 | Breast hyperplasia | FAERS: 1 | OFFSIDES US FAERS | |
| 662 | Bronchopneumonia | FAERS: 1 | US FAERS | |
| 663 | Bunion operation | FAERS: 1 | US FAERS | |
| 664 | Bursitis | FAERS: 1 | OFFSIDES US FAERS | |
| 665 | Carbohydrate tolerance decreased | FAERS: 1 | SIDER US FAERS | |
| 666 | Carcinoembryonic antigen increased | FAERS: 1 | US FAERS | |
| 667 | Cardiac ablation | FAERS: 1 | US FAERS | |
| 668 | Cardiac assistance device user | FAERS: 1 | US FAERS | |
| 669 | Carpal Tunnel Syndrome | FAERS: 1 | SIDER US FAERS | |
| 670 | Caustic injury | FAERS: 1 | US FAERS | |
| 671 | Cellulitis | FAERS: 1 | US FAERS | |
| 672 | Cerebral atrophy | FAERS: 1 | US FAERS | |
| 673 | Cerebral microhaemorrhage | FAERS: 1 | US FAERS | |
| 674 | Cervical friability | FAERS: 1 | US FAERS | |
| 675 | Cervical polyp | FAERS: 1 | SIDER US FAERS | |
| 676 | Cervix carcinoma | FAERS: 1 | US FAERS | |
| 677 | Chemotherapy | FAERS: 1 | US FAERS | |
| 678 | Choking | FAERS: 1 | US FAERS | |
| 679 | Chronic Fatigue Syndrome | FAERS: 1 | OFFSIDES US FAERS | |
| 680 | Clumsiness | FAERS: 1 | US FAERS | |
| 681 | Cluster Headache | FAERS: 1 | US FAERS | |
| 682 | Coital bleeding | FAERS: 1 | US FAERS | |
| 683 | Colonic Stenosis | FAERS: 1 | US FAERS | |
| 684 | Complication of device insertion | FAERS: 1 | US FAERS | |
| 685 | Complications of bone marrow transplant | FAERS: 1 | US FAERS | |
| 686 | Congenital pneumonia | FAERS: 1 | US FAERS | |
| 687 | Conjunctival cyst | FAERS: 1 | US FAERS | |
| 688 | Conjunctivitis | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 689 | Croup infectious | FAERS: 1 | US FAERS | |
| 690 | Cyanosis | FAERS: 1 | US FAERS | |
| 691 | Cystitis-like symptom | FAERS: 1 | US FAERS | |
| 692 | Cystoscopy | FAERS: 1 | US FAERS | |
| 693 | Dark circles under eyes | FAERS: 1 | US FAERS | |
| 694 | Dehydroepiandrosterone increased | FAERS: 1 | US FAERS | |
| 695 | Dengue Fever | FAERS: 1 | US FAERS | |
| 696 | Dental caries | FAERS: 1 | OFFSIDES US FAERS | |
| 697 | Depression suicidal | FAERS: 1 | OFFSIDES US FAERS | |
| 698 | Dermal absorption increased | FAERS: 1 | US FAERS | |
| 699 | Dermatitis Herpetiformis | FAERS: 1 | US FAERS | |
| 700 | Device breakage | FAERS: 1 | OFFSIDES US FAERS | |
| 701 | Device component issue | FAERS: 1 | US FAERS | |
| 702 | Device deposit issue | FAERS: 1 | US FAERS | |
| 703 | Device dislocation | FAERS: 1 | US FAERS | |
| 704 | Device ineffective | FAERS: 1 | US FAERS | |
| 705 | Device intolerance | FAERS: 1 | US FAERS | |
| 706 | Device used for unapproved schedule | FAERS: 1 | US FAERS | |
| 707 | Disseminated Intravascular Coagulation | FAERS: 1 | 65916 | CTD US FAERS |
| 708 | Drug Tolerance | FAERS: 1 | US FAERS | |
| 709 | Drug dispensed to wrong patient | FAERS: 1 | US FAERS | |
| 710 | Drug dose titration not performed | FAERS: 1 | US FAERS | |
| 711 | Drug effect variable | FAERS: 1 | US FAERS | |
| 712 | Drug exposure during pregnancy | FAERS: 1 | US FAERS | |
| 713 | Drug level changed | FAERS: 1 | US FAERS | |
| 714 | Drug level increased | FAERS: 1 | US FAERS | |
| 715 | Drug screen positive | FAERS: 1 | US FAERS | |
| 716 | Duodenal Ulcer | FAERS: 1 | US FAERS | |
| 717 | Dysgraphia | FAERS: 1 | US FAERS | |
| 718 | Dysphemia | FAERS: 1 | US FAERS | |
| 719 | Eczema weeping | FAERS: 1 | US FAERS | |
| 720 | Educational problem | FAERS: 1 | US FAERS | |
| 721 | Electrocardiogram ST-T segment abnormal | FAERS: 1 | US FAERS | |
| 722 | Electrolyte imbalance | FAERS: 1 | US FAERS | |
| 723 | Encephalitis | FAERS: 1 | US FAERS | |
| 724 | Encephalomalacia | FAERS: 1 | US FAERS | |
| 725 | Endodontic procedure | FAERS: 1 | US FAERS | |
| 726 | Endometrial adenocarcinoma | FAERS: 1 | US FAERS | |
| 727 | Endometrial cancer stage III | FAERS: 1 | US FAERS | |
| 728 | Endotracheal intubation complication | FAERS: 1 | US FAERS | |
| 729 | Euphoric mood | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 730 | Excoriation | FAERS: 1 | US FAERS | |
| 731 | Exertional headache | FAERS: 1 | US FAERS | |
| 732 | Exophthalmos | FAERS: 1 | US FAERS | |
| 733 | Exposure during breast feeding | FAERS: 1 | US FAERS | |
| 734 | Exposure via direct contact | FAERS: 1 | US FAERS | |
| 735 | Eye complication associated with device | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 736 | Eye inflammation | FAERS: 1 | OFFSIDES US FAERS | |
| 737 | Eye pain | FAERS: 1 Canada Vigilance: 4 | Canada Vigilance OFFSIDES US FAERS | |
| 738 | Feelings of worthlessness | FAERS: 1 | US FAERS | |
| 739 | Female sex hormone level abnormal | FAERS: 1 | US FAERS | |
| 740 | Fibroadenoma of breast | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance OFFSIDES US FAERS | |
| 741 | Food Allergy | FAERS: 1 | US FAERS | |
| 742 | Food Poisoning | FAERS: 1 | OFFSIDES US FAERS | |
| 743 | Foreign body sensation in eyes | FAERS: 1 | US FAERS | |
| 744 | Frustration | FAERS: 1 | US FAERS | |
| 745 | Gallbladder pain | FAERS: 1 | US FAERS | |
| 746 | Gastric Bypass | FAERS: 1 | US FAERS | |
| 747 | Gastroenteritis | FAERS: 1 | OFFSIDES SIDER US FAERS | |
| 748 | Gastrointestinal bacterial overgrowth | FAERS: 1 | US FAERS | |
| 749 | Gastrointestinal disorder postoperative | FAERS: 1 | US FAERS | |
| 750 | Gastrointestinal inflammation | FAERS: 1 | US FAERS | |
| 751 | Gastrointestinal sounds abnormal | FAERS: 1 | US FAERS | |
| 752 | Gender Dysphoria | FAERS: 1 | US FAERS | |
| 753 | General symptom | FAERS: 1 | US FAERS | |
| 754 | Genetic Polymorphism | FAERS: 1 | US FAERS | |
| 755 | Genital atrophy | FAERS: 1 | US FAERS | |
| 756 | Genital contusion | FAERS: 1 | US FAERS | |
| 757 | Genital cyst | FAERS: 1 | US FAERS | |
| 758 | Genital swelling | FAERS: 1 | US FAERS | |
| 759 | Gingival Recession | FAERS: 1 | US FAERS | |
| 760 | Gluten sensitivity | FAERS: 1 | US FAERS | |
| 761 | Granulomatous liver disease | FAERS: 1 | US FAERS | |
| 762 | Head discomfort | FAERS: 1 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 763 | Hemiplegia | FAERS: 1 | US FAERS | |
| 764 | Hepatic congestion | FAERS: 1 | US FAERS | |
| 765 | Hepatitis C antibody positive | FAERS: 1 | US FAERS | |
| 766 | Hordeolum | FAERS: 1 | US FAERS | |
| 767 | Hunger | FAERS: 1 | US FAERS | |
| 768 | Hydrometra | FAERS: 1 | US FAERS | |
| 769 | Hydronephrosis | FAERS: 1 | 4057428 | CTD OFFSIDES US FAERS |
| 770 | Hyperacusis | FAERS: 1 | US FAERS | |
| 771 | Hyperchlorhydria | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 772 | Hyperphagia | FAERS: 1 | US FAERS | |
| 773 | Hypertensive crisis | FAERS: 1 | US FAERS | |
| 774 | Hypoaesthesia facial | FAERS: 1 | US FAERS | |
| 775 | Hypokinesia | FAERS: 1 | OFFSIDES US FAERS | |
| 776 | Hypophagia | FAERS: 1 | US FAERS | |
| 777 | Hypotension | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 778 | Hypothalamo-pituitary disorder | FAERS: 1 | US FAERS | |
| 779 | Impaired gastric emptying | FAERS: 1 | US FAERS | |
| 780 | Impetigo | FAERS: 1 | US FAERS | |
| 781 | Inability to afford medication | FAERS: 1 | US FAERS | |
| 782 | Inadequate aseptic technique in use of product | FAERS: 1 | US FAERS | |
| 783 | Incorrect drug administration rate | FAERS: 1 | US FAERS | |
| 784 | Increased upper airway secretion | FAERS: 1 | US FAERS | |
| 785 | Infrequent bowel movements | FAERS: 1 | US FAERS | |
| 786 | Injection site pruritus | FAERS: 1 | OFFSIDES US FAERS | |
| 787 | Insurance issue | FAERS: 1 | US FAERS | |
| 788 | Intentional device misuse | FAERS: 1 | US FAERS | |
| 789 | Intercepted drug administration error | FAERS: 1 | US FAERS | |
| 790 | Intercepted drug dispensing error | FAERS: 1 | US FAERS | |
| 791 | Intercepted product storage error | FAERS: 1 | US FAERS | |
| 792 | Intermittent Claudication | FAERS: 1 | US FAERS | |
| 793 | Intervertebral Disc Degeneration | FAERS: 1 | OFFSIDES US FAERS | |
| 794 | Intestinal Perforation | FAERS: 1 | US FAERS | |
| 795 | Intestinal cyst | FAERS: 1 | US FAERS | |
| 796 | Intracranial meningioma malignant | FAERS: 1 | US FAERS | |
| 797 | Intraductal papilloma of breast | FAERS: 1 | OFFSIDES US FAERS | |
| 798 | Invasive Ductal Breast Carcinoma | FAERS: 1 | US FAERS | |
| 799 | Joint Range of Motion Decreased | FAERS: 1 | OFFSIDES US FAERS | |
| 800 | Joint stiffness | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 801 | Lactose Intolerance | FAERS: 1 | US FAERS | |
| 802 | Laparotomy | FAERS: 1 | US FAERS | |
| 803 | Laryngitis | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 804 | Leukocytosis | FAERS: 1 | US FAERS | |
| 805 | Lip exfoliation | FAERS: 1 | US FAERS | |
| 806 | Lipase increased | FAERS: 1 | US FAERS | |
| 807 | Loss of personal independence in daily activities | FAERS: 1 | US FAERS | |
| 808 | Low birth weight baby | FAERS: 1 | US FAERS | |
| 809 | Low density lipoprotein increased | FAERS: 1 | US FAERS | |
| 810 | Lung neoplasm surgery | FAERS: 1 | US FAERS | |
| 811 | MYELODYSPLASTIC SYNDROME | FAERS: 1 | US FAERS | |
| 812 | Male sexual dysfunction | FAERS: 1 | US FAERS | |
| 813 | Malignant Hypertension | FAERS: 1 | US FAERS | |
| 814 | Malignant melanoma of sites other than skin | FAERS: 1 | US FAERS | |
| 815 | Malignant neoplasm progression | FAERS: 1 | US FAERS | |
| 816 | Maternal exposure timing unspecified | FAERS: 1 | US FAERS | |
| 817 | Medial Tibial Stress Syndrome | FAERS: 1 | US FAERS | |
| 818 | Medical device pain | FAERS: 1 | US FAERS | |
| 819 | Medical device site reaction | FAERS: 1 | US FAERS | |
| 820 | Medication residue | FAERS: 1 | OFFSIDES US FAERS | |
| 821 | Milk soy protein intolerance | FAERS: 1 | US FAERS | |
| 822 | Monoplegia | FAERS: 1 | US FAERS | |
| 823 | Morning Sickness | FAERS: 1 | US FAERS | |
| 824 | Mouth swelling | FAERS: 1 | US FAERS | |
| 825 | Multiple allergies | FAERS: 1 | US FAERS | |
| 826 | Muscle Cramp | FAERS: 1 | US FAERS | |
| 827 | Myelofibrosis | FAERS: 1 | US FAERS | |
| 828 | Myocardial fibrosis | FAERS: 1 | US FAERS | |
| 829 | Necrosis | FAERS: 1 | 25280774 | CTD US FAERS |
| 830 | Negative thoughts | FAERS: 1 | OFFSIDES US FAERS | |
| 831 | Neoplasm of cornea unspecified malignancy | FAERS: 1 | US FAERS | |
| 832 | Nephrosclerosis | FAERS: 1 | US FAERS | |
| 833 | No reaction on previous exposure to drug | FAERS: 1 | US FAERS | |
| 834 | Nodule | FAERS: 1 | OFFSIDES US FAERS | |
| 835 | Obsessive thoughts | FAERS: 1 | US FAERS | |
| 836 | Obstruction | FAERS: 1 | US FAERS | |
| 837 | Oliguria | FAERS: 1 | US FAERS | |
| 838 | Oral administration complication | FAERS: 1 | US FAERS | |
| 839 | Oral mucosal eruption | FAERS: 1 | US FAERS | |
| 840 | Oral pruritus | FAERS: 1 | US FAERS | |
| 841 | Orgasmic sensation decreased | FAERS: 1 | US FAERS | |
| 842 | Oropharyngeal discomfort | FAERS: 1 | US FAERS | |
| 843 | Orthostatic hypertension | FAERS: 1 | US FAERS | |
| 844 | Ovarian cancer stage III | FAERS: 1 | US FAERS | |
| 845 | Overweight | FAERS: 1 | US FAERS | |
| 846 | Packaging design issue | FAERS: 1 | US FAERS | |
| 847 | Papilloma | FAERS: 1 | US FAERS | |
| 848 | Papule | FAERS: 1 | SIDER US FAERS | |
| 849 | Pathological fracture | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 850 | Pelvic mass | FAERS: 1 | US FAERS | |
| 851 | Pelvic operation | FAERS: 1 | US FAERS | |
| 852 | Penile burning sensation | FAERS: 1 | US FAERS | |
| 853 | Performance status decreased | FAERS: 1 | US FAERS | |
| 854 | Perineal erythema | FAERS: 1 | US FAERS | |
| 855 | Perineal injury | FAERS: 1 | US FAERS | |
| 856 | Pharmaceutical product counterfeit | FAERS: 1 | US FAERS | |
| 857 | Pharyngitis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 858 | Photophobia | FAERS: 1 | US FAERS | |
| 859 | Poisoning | FAERS: 1 | US FAERS | |
| 860 | Polyuria | FAERS: 1 | SIDER US FAERS | |
| 861 | Poor peripheral circulation | FAERS: 1 | US FAERS | |
| 862 | Portal Vein Thrombosis | FAERS: 1 | US FAERS | |
| 863 | Posterior reversible encephalopathy syndrome | FAERS: 1 | US FAERS | |
| 864 | Pregnancy on contraceptive | FAERS: 1 | US FAERS | |
| 865 | Pregnancy | FAERS: 1 | US FAERS | |
| 866 | Premature Menopause | FAERS: 1 | US FAERS | |
| 867 | Prescription drug used without a prescription | FAERS: 1 | US FAERS | |
| 868 | Procedural complication | FAERS: 1 | US FAERS | |
| 869 | Proctitis | FAERS: 1 | US FAERS | |
| 870 | Product closure removal difficult | FAERS: 1 | US FAERS | |
| 871 | Product contamination chemical | FAERS: 1 | US FAERS | |
| 872 | Product contamination physical | FAERS: 1 | US FAERS | |
| 873 | Product deposit | FAERS: 1 | US FAERS | |
| 874 | Product distribution issue | FAERS: 1 | US FAERS | |
| 875 | Product expiration date issue | FAERS: 1 | US FAERS | |
| 876 | Product identification number issue | FAERS: 1 | US FAERS | |
| 877 | Product label confusion | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 878 | Product label issue | FAERS: 1 | US FAERS | |
| 879 | Product leakage | FAERS: 1 | US FAERS | |
| 880 | Product process control issue | FAERS: 1 | US FAERS | |
| 881 | Product supply issue | FAERS: 1 | US FAERS | |
| 882 | Protein urine present | FAERS: 1 | US FAERS | |
| 883 | Pterygium | FAERS: 1 | US FAERS | |
| 884 | Puberty | FAERS: 1 | US FAERS | |
| 885 | Pulmonary Infarction | FAERS: 1 | US FAERS | |
| 886 | Pulmonary arterial hypertension | FAERS: 1 | US FAERS | |
| 887 | Pulmonary artery thrombosis | FAERS: 1 | US FAERS | |
| 888 | Purpura | FAERS: 1 Canada Vigilance: 8 | Canada Vigilance SIDER US FAERS | |
| 889 | Radiation thyroiditis | FAERS: 1 | US FAERS | |
| 890 | Reaction to azo-dyes | FAERS: 1 | US FAERS | |
| 891 | Reaction to excipient | FAERS: 1 | US FAERS | |
| 892 | Rebound psychosis | FAERS: 1 | US FAERS | |
| 893 | Recalled product administered | FAERS: 1 | US FAERS | |
| 894 | Renal Colic | FAERS: 1 | US FAERS | |
| 895 | Renal cyst | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 896 | Renal mass | FAERS: 1 | US FAERS | |
| 897 | Renal pain | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 898 | Renal tubular necrosis | FAERS: 1 | US FAERS | |
| 899 | Renal vein occlusion | FAERS: 1 | US FAERS | |
| 900 | Respiratory arrest | FAERS: 1 | US FAERS | |
| 901 | Respiratory distress | FAERS: 1 | US FAERS | |
| 902 | Respiratory tract irritation | FAERS: 1 | US FAERS | |
| 903 | Rubber sensitivity | FAERS: 1 | US FAERS | |
| 904 | Schizophrenia | FAERS: 1 | US FAERS | |
| 905 | Scleroderma | FAERS: 1 | US FAERS | |
| 906 | Septic Shock | FAERS: 1 | US FAERS | |
| 907 | Seroma | FAERS: 1 | OFFSIDES US FAERS | |
| 908 | Sexual relationship change | FAERS: 1 | US FAERS | |
| 909 | Sinus Tachycardia | FAERS: 1 | US FAERS | |
| 910 | Sinus bradycardia | FAERS: 1 | OFFSIDES US FAERS | |
| 911 | Sinus operation | FAERS: 1 | US FAERS | |
| 912 | Skeletal injury | FAERS: 1 | OFFSIDES US FAERS | |
| 913 | Skin discomfort | FAERS: 1 | US FAERS | |
| 914 | Skin hypertrophy | FAERS: 1 | SIDER US FAERS | |
| 915 | Skin nodule | FAERS: 1 | US FAERS | |
| 916 | Skin pressure mark | FAERS: 1 | US FAERS | |
| 917 | Skin texture abnormal | FAERS: 1 | US FAERS | |
| 918 | Sphincter of Oddi Dysfunction | FAERS: 1 | US FAERS | |
| 919 | Strabismus | FAERS: 1 | US FAERS | |
| 920 | Stroke in evolution | FAERS: 1 | US FAERS | |
| 921 | Suicide of relative | FAERS: 1 | US FAERS | |
| 922 | Suspected product contamination | FAERS: 1 | US FAERS | |
| 923 | Suspected transmission of an infectious agent via product | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 924 | Syringe issue | FAERS: 1 | US FAERS | |
| 925 | Tachyphrenia | FAERS: 1 | US FAERS | |
| 926 | Therapeutic product contamination | FAERS: 1 | US FAERS | |
| 927 | Therapy regimen changed | FAERS: 1 | US FAERS | |
| 928 | Throat cancer | FAERS: 1 | US FAERS | |
| 929 | Thyroid hormones decreased | FAERS: 1 | US FAERS | |
| 930 | Thyroidectomy | FAERS: 1 | US FAERS | |
| 931 | Tissue injury | FAERS: 1 | US FAERS | |
| 932 | Tongue discomfort | FAERS: 1 | US FAERS | |
| 933 | Tooth Infection | FAERS: 1 | OFFSIDES US FAERS | |
| 934 | Transcription medication error | FAERS: 1 | US FAERS | |
| 935 | Trichorrhexis | FAERS: 1 | US FAERS | |
| 936 | Trisomy 21 | FAERS: 1 | US FAERS | |
| 937 | Tubal Ligation | FAERS: 1 | US FAERS | |
| 938 | Tuberculosis | FAERS: 1 | US FAERS | |
| 939 | Ultrasound breast abnormal | FAERS: 1 | OFFSIDES US FAERS | |
| 940 | Ultrasound scan abnormal | FAERS: 1 | US FAERS | |
| 941 | Umbilical hernia | FAERS: 1 | US FAERS | |
| 942 | Unintentional medical device removal | FAERS: 1 | US FAERS | |
| 943 | Unresponsive to stimuli | FAERS: 1 | US FAERS | |
| 944 | Urethral caruncle | FAERS: 1 | US FAERS | |
| 945 | Urethral spasm | FAERS: 1 | US FAERS | |
| 946 | Urinary Retention | FAERS: 1 Canada Vigilance: 1 | 4057428 4057429 19181629 | CTD Canada Vigilance US FAERS |
| 947 | Urinary ascites | FAERS: 1 | US FAERS | |
| 948 | Urinary tract discomfort | FAERS: 1 | US FAERS | |
| 949 | Urinary tract infection staphylococcal | FAERS: 1 | US FAERS | |
| 950 | Urine output increased | FAERS: 1 | SIDER US FAERS | |
| 951 | Urticaria localised | FAERS: 1 | US FAERS | |
| 952 | Uterovaginal prolapse | FAERS: 1 | US FAERS | |
| 953 | Vaginal hyperplasia | FAERS: 1 | US FAERS | |
| 954 | Vaginitis | FAERS: 1 | US FAERS | |
| 955 | Vascular pain | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 956 | Vascular purpura | FAERS: 1 | SIDER US FAERS | |
| 957 | Vascular rupture | FAERS: 1 | US FAERS | |
| 958 | Vena cava filter insertion | FAERS: 1 | US FAERS | |
| 959 | Venous stenosis | FAERS: 1 | US FAERS | |
| 960 | Vitamin B6 increased | FAERS: 1 | US FAERS | |
| 961 | Vitreous floaters | FAERS: 1 | US FAERS | |
| 962 | Vulvovaginal rash | FAERS: 1 | US FAERS | |
| 963 | Wound Infection | FAERS: 1 | US FAERS | |
| 964 | Wrong product administered | FAERS: 1 | US FAERS | |
| 965 | Wrong schedule | FAERS: 1 | US FAERS | |
| 966 | diagnostic procedure | FAERS: 1 | US FAERS | |
| 967 | effusion | FAERS: 1 | US FAERS | |
| 968 | pH body fluid abnormal | FAERS: 1 | US FAERS | |
| 969 | Abdominal Cramps | SIDER | ||
| 970 | Abdominal bloating | SIDER | ||
| 971 | Abdominal symptom | OFFSIDES | ||
| 972 | Abnormal cervical smear | OFFSIDES | ||
| 973 | Abnormal vision | SIDER | ||
| 974 | Abnormalities, Drug-Induced | 12507662 29458080 | CTD | |
| 975 | Abuse | OFFSIDES | ||
| 976 | Acanthosis | OFFSIDES | ||
| 977 | Ache | SIDER | ||
| 978 | Acid reflux | OFFSIDES | ||
| 979 | Actinic keratosis | OFFSIDES | ||
| 980 | Activated Protein C Resistance | 11703344 | CTD | |
| 981 | Acute bronchitis | OFFSIDES | ||
| 982 | Acute sinusitis | OFFSIDES | ||
| 983 | Adenocarcinoma | CTD OFFSIDES | ||
| 984 | Adrenal mass | OFFSIDES | ||
| 985 | Ageusia | OFFSIDES | ||
| 986 | Airway Obstruction | 30445053 | CTD | |
| 987 | Albuminuria | 2372993 | CTD | |
| 988 | Alcohol Intolerance | Canada Vigilance: 1 | Canada Vigilance | |
| 989 | Altered bowel function | OFFSIDES | ||
| 990 | Alveolitis | OFFSIDES | ||
| 991 | Amblyopia | OFFSIDES | ||
| 992 | Anaphylactoid Reaction | SIDER | ||
| 993 | Aneuploidy | 10728588 | CTD | |
| 994 | Anhidrosis | OFFSIDES | ||
| 995 | Anxiety Disorders | 30565903 | CTD | |
| 996 | Aortic Aneurysm | OFFSIDES | ||
| 997 | Aortic aneurysm repair | OFFSIDES | ||
| 998 | Aortic valve sclerosis | OFFSIDES | ||
| 999 | Appendectomy | OFFSIDES | ||
| 1000 | Arteriosclerosis | OFFSIDES | ||
| 1001 | Arthritis aggravated | SIDER | ||
| 1002 | Arthropod bite | OFFSIDES SIDER | ||
| 1003 | Arthroscopy | OFFSIDES | ||
| 1004 | Atherosclerosis | 12020746 | CTD OFFSIDES | |
| 1005 | Auricular swelling | OFFSIDES | ||
| 1006 | Autoimmune inner ear disease | OFFSIDES | ||
| 1007 | BREAST PAIN FEMALE | SIDER | ||
| 1008 | Bereavement | OFFSIDES | ||
| 1009 | Biliary adenoma | OFFSIDES | ||
| 1010 | Biopsy breast abnormal | Canada Vigilance: 1 | Canada Vigilance OFFSIDES | |
| 1011 | Biopsy endometrium abnormal | Canada Vigilance: 1 | Canada Vigilance | |
| 1012 | Biopsy | OFFSIDES | ||
| 1013 | Bipolar I disorder | OFFSIDES | ||
| 1014 | Bladder cancer recurrent | OFFSIDES | ||
| 1015 | Blepharitis | OFFSIDES SIDER | ||
| 1016 | Blood 1,25-dihydroxycholecalciferol decreased | OFFSIDES | ||
| 1017 | Blood alkaline phosphatase | OFFSIDES | ||
| 1018 | Blood and lymphatic system disorders | SIDER | ||
| 1019 | Blood chloride increased | OFFSIDES | ||
| 1020 | Blood cholesterol | OFFSIDES | ||
| 1021 | Blood chromogranin A increased | OFFSIDES | ||
| 1022 | Blood immunoglobulin E | OFFSIDES | ||
| 1023 | Blood iron decreased | OFFSIDES | ||
| 1024 | Blood pressure inadequately controlled | OFFSIDES | ||
| 1025 | Blood thyroid stimulating hormone increased | OFFSIDES | ||
| 1026 | Blurred vision | OFFSIDES | ||
| 1027 | Bone Marrow Diseases | 6729802 | CTD | |
| 1028 | Brain Concussion | OFFSIDES | ||
| 1029 | Brain Diseases | 15725413 | CTD | |
| 1030 | Brain Injuries | 9972699 12757899 | CTD | |
| 1031 | Brain natriuretic peptide increased | OFFSIDES | ||
| 1032 | Breast fibroma | OFFSIDES | ||
| 1033 | Bronchiectasis | Canada Vigilance: 1 | Canada Vigilance | |
| 1034 | Bronchoalveolar lavage abnormal | OFFSIDES | ||
| 1035 | Bulbar palsy | OFFSIDES | ||
| 1036 | Calcinosis | Canada Vigilance: 2 | Canada Vigilance | |
| 1037 | Candidiasis of vagina | OFFSIDES | ||
| 1038 | Candidiasis, Vulvovaginal | 16111702 | CTD | |
| 1039 | Carcinoma, Endometrioid | 10340283 | CTD | |
| 1040 | Cardiac enzymes increased | OFFSIDES | ||
| 1041 | Cardiac infection | OFFSIDES | ||
| 1042 | Cardioactive drug level increased | OFFSIDES | ||
| 1043 | Carotid Artery Thrombosis | Canada Vigilance: 1 | 8638876 | CTD Canada Vigilance |
| 1044 | Catalepsy | CTD | ||
| 1045 | Catheter sepsis | OFFSIDES | ||
| 1046 | Cerebral Hemorrhage | 8638876 | CTD | |
| 1047 | Cerebral artery occlusion | OFFSIDES | ||
| 1048 | Cervicobrachial syndrome | OFFSIDES | ||
| 1049 | Chemical and Drug Induced Liver Injury | 20933533 21501669 22157104 | CTD | |
| 1050 | Chemically-Induced Disorders | 30445053 | CTD | |
| 1051 | Chest wall pain | OFFSIDES | ||
| 1052 | Choking sensation | OFFSIDES | ||
| 1053 | Cholelithotomy | OFFSIDES | ||
| 1054 | Chorea | SIDER | ||
| 1055 | Chromosome Aberrations | 21059909 | CTD | |
| 1056 | Chronic sinusitis | OFFSIDES | ||
| 1057 | Chronic ulcerative colitis | OFFSIDES | ||
| 1058 | Clostridium difficile colitis | OFFSIDES | ||
| 1059 | Cocaine-Related Disorders | CTD | ||
| 1060 | Cognition Disorders | 11967638 | CTD | |
| 1061 | Common Cold | SIDER | ||
| 1062 | Congenital cystic kidney disease | OFFSIDES | ||
| 1063 | Congenital tricuspid valve incompetence | OFFSIDES | ||
| 1064 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 18184636 | CTD | |
| 1065 | Contact Dermatitis | OFFSIDES | ||
| 1066 | Conversion disorder | OFFSIDES | ||
| 1067 | Coronary angioplasty | OFFSIDES | ||
| 1068 | Cramps of lower extremities | SIDER | ||
| 1069 | Craniofacial Abnormalities | 29499231 | CTD | |
| 1070 | Culture positive | OFFSIDES | ||
| 1071 | Deafness Neurosensory | OFFSIDES | ||
| 1072 | Decreased immune responsiveness | OFFSIDES | ||
| 1073 | Demyelinating Diseases | 19031445 | CTD | |
| 1074 | Demyelination | OFFSIDES | ||
| 1075 | Dental abscess | OFFSIDES | ||
| 1076 | Dependence | OFFSIDES | ||
| 1077 | Dependent Personality Disorder | OFFSIDES | ||
| 1078 | Depressive disorder | CTD | ||
| 1079 | Dermatitis hemorrhagic | SIDER | ||
| 1080 | Dermatitis, Allergic Contact | 30017638 | CTD | |
| 1081 | Dermoid Cyst | OFFSIDES | ||
| 1082 | Diabetic Foot | OFFSIDES | ||
| 1083 | Diaphragmatic Hernia | OFFSIDES | ||
| 1084 | Diarrhea | OFFSIDES | ||
| 1085 | Diastolic dysfunction | OFFSIDES | ||
| 1086 | Dihydrotestosterone decreased | OFFSIDES | ||
| 1087 | Disorders of Sex Development | 2340337 2340338 19008211 | CTD | |
| 1088 | Disturbance in sexual arousal | SIDER | ||
| 1089 | Diverticulum | OFFSIDES | ||
| 1090 | Drowsiness | OFFSIDES | ||
| 1091 | Dyschezia | OFFSIDES | ||
| 1092 | Dyslexia | OFFSIDES | ||
| 1093 | Dysmenorrhea | OFFSIDES | ||
| 1094 | Ear and labyrinth disorders | SIDER | ||
| 1095 | Ecchymosis | Canada Vigilance: 1 | Canada Vigilance | |
| 1096 | Ectropion of cervix | SIDER | ||
| 1097 | Edema | 4057428 15364205 30017638 | CTD | |
| 1098 | Ejection Fraction Decreased | OFFSIDES | ||
| 1099 | Electrocardiogram ST segment abnormal | OFFSIDES | ||
| 1100 | Electrocardiogram change | OFFSIDES | ||
| 1101 | Embryo Loss | 30061528 | CTD | |
| 1102 | Endocervical curettage | OFFSIDES | ||
| 1103 | Endometrial Neoplasms | CTD | ||
| 1104 | Endometrial cancer stage II | OFFSIDES | ||
| 1105 | Endophthalmitis | SIDER | ||
| 1106 | Enlargement abdomen | SIDER | ||
| 1107 | Esophageal Stenosis | OFFSIDES | ||
| 1108 | Essential Hypertension | OFFSIDES | ||
| 1109 | Ethmoid sinus surgery | OFFSIDES | ||
| 1110 | Exacerbation of asthma | SIDER | ||
| 1111 | Facial Neuralgia | OFFSIDES | ||
| 1112 | Facial rash | SIDER | ||
| 1113 | Fat necrosis | OFFSIDES | ||
| 1114 | Fatty Liver | 27014939 | CTD OFFSIDES | |
| 1115 | Fetal Death | 65916 | CTD | |
| 1116 | Food craving | Canada Vigilance: 2 | Canada Vigilance | |
| 1117 | Gallop rhythm present | OFFSIDES | ||
| 1118 | Gambling | OFFSIDES | ||
| 1119 | Gingivitis | Canada Vigilance: 1 | Canada Vigilance | |
| 1120 | Gliosis | 19031445 | CTD | |
| 1121 | Hematuria | 2372993 | CTD | |
| 1122 | Hepatic Infection | OFFSIDES | ||
| 1123 | Hernia | Canada Vigilance: 1 | Canada Vigilance | |
| 1124 | High density lipoprotein increased | OFFSIDES | ||
| 1125 | Hyperalgesia | 12809704 | CTD | |
| 1126 | Hyperglycemia | 20801139 25859628 | CTD | |
| 1127 | Hyperprolactinemia | CTD | ||
| 1128 | Hypertrichosis | Canada Vigilance: 1 | Canada Vigilance | |
| 1129 | Hypertriglyceridemia | 20337216 | CTD | |
| 1130 | Hypertrophy | 8010988 | CTD | |
| 1131 | Hyporeflexia | OFFSIDES | ||
| 1132 | Hysteroscopy | OFFSIDES | ||
| 1133 | Incision site complication | OFFSIDES | ||
| 1134 | Increased bronchial secretion | OFFSIDES | ||
| 1135 | Increased tendency to bruise | SIDER | ||
| 1136 | Infarction, Middle Cerebral Artery | 21277368 | CTD | |
| 1137 | Infectious Mononucleosis | OFFSIDES | ||
| 1138 | Infestation | SIDER | ||
| 1139 | Influenza-like symptoms | SIDER | ||
| 1140 | Infusion site mobility decreased | OFFSIDES | ||
| 1141 | Infusion site swelling | OFFSIDES | ||
| 1142 | Injection Site Reaction | Canada Vigilance: 2 | Canada Vigilance | |
| 1143 | Injection site dermatitis | OFFSIDES | ||
| 1144 | Injection site erythema | OFFSIDES | ||
| 1145 | Injection site laceration | OFFSIDES | ||
| 1146 | Injection site phlebitis | OFFSIDES | ||
| 1147 | Injection site warmth | OFFSIDES | ||
| 1148 | Insulin Resistance | 16393666 16627594 25859628 | CTD | |
| 1149 | Intention tremor | OFFSIDES | ||
| 1150 | Intervertebral disc disorder | OFFSIDES | ||
| 1151 | Intrinsic factor antibody negative | OFFSIDES | ||
| 1152 | Jaundice, Obstructive | 7866818 | CTD | |
| 1153 | Joint Instability | OFFSIDES | ||
| 1154 | Joint sprain | OFFSIDES SIDER | ||
| 1155 | Keratosis | 30017638 | CTD | |
| 1156 | Kidney Diseases | 6305905 15618244 | CTD | |
| 1157 | Kidney Failure | OFFSIDES | ||
| 1158 | Leg edema | SIDER | ||
| 1159 | Legionella | OFFSIDES | ||
| 1160 | Lesion excision | OFFSIDES | ||
| 1161 | Leukorrhea | SIDER | ||
| 1162 | Ligament injury | OFFSIDES | ||
| 1163 | Ligament rupture | OFFSIDES | ||
| 1164 | Liver Cirrhosis, Experimental | 14659978 14716833 | CTD | |
| 1165 | Liver Neoplasms, Experimental | 21984479 | CTD | |
| 1166 | Liver diseases | 20337216 | CTD | |
| 1167 | Loose tooth | OFFSIDES | ||
| 1168 | Lordosis | OFFSIDES | ||
| 1169 | Lung diseases | 21129541 | CTD | |
| 1170 | Lupus Erythematosus, Systemic | 17578864 | CTD | |
| 1171 | Lymphedema | OFFSIDES | ||
| 1172 | Mammary Neoplasms, Experimental | CTD | ||
| 1173 | Mammary duct ectasia | OFFSIDES | ||
| 1174 | Manganese Poisoning | 19383943 19453300 29183790 | CTD | |
| 1175 | Mechanical urticaria | OFFSIDES | ||
| 1176 | Medulloblastoma | 21351254 | CTD | |
| 1177 | Memory Disorders | 8675575 10672254 11967638 | CTD | |
| 1178 | Metaplasia | OFFSIDES | ||
| 1179 | Metastatic Neoplasm | OFFSIDES | ||
| 1180 | Metatarsalgia | OFFSIDES | ||
| 1181 | Microcephaly | 15364205 | CTD | |
| 1182 | Migraine aggravated | SIDER | ||
| 1183 | Mitral valve sclerosis | OFFSIDES | ||
| 1184 | Modified radical mastectomy | OFFSIDES | ||
| 1185 | Mood Disorders | 12727949 | CTD | |
| 1186 | Movement Disorders | 29183790 | CTD | |
| 1187 | Muscle Weakness | OFFSIDES | ||
| 1188 | Mycosis Fungoides | OFFSIDES | ||
| 1189 | Myelodysplasia | OFFSIDES | ||
| 1190 | Myocardial Reperfusion Injury | 16810080 | CTD | |
| 1191 | Myoclonus | SIDER | ||
| 1192 | Myokymia | OFFSIDES | ||
| 1193 | Myopia | Canada Vigilance: 2 | Canada Vigilance | |
| 1194 | Neck stiffness | SIDER | ||
| 1195 | Neoplasm Invasiveness | 2846159 15802018 26990689 | CTD | |
| 1196 | Neoplasms, Experimental | CTD | ||
| 1197 | Neoplasms | 821748 | CTD | |
| 1198 | Nerve Block | OFFSIDES | ||
| 1199 | Nerve Degeneration | 16951259 21512103 22645130 | CTD | |
| 1200 | Nervous tension | OFFSIDES | ||
| 1201 | Neuritis | SIDER | ||
| 1202 | Neuroma | OFFSIDES | ||
| 1203 | Neuropathic pain | OFFSIDES | ||
| 1204 | Nocturia | OFFSIDES | ||
| 1205 | Non-cardiac chest pain | OFFSIDES | ||
| 1206 | Nuchal Rigidity | SIDER | ||
| 1207 | Numbness | SIDER | ||
| 1208 | Obesity | Canada Vigilance: 1 | Canada Vigilance | |
| 1209 | Obsessive-Compulsive Disorder | 9847494 | CTD | |
| 1210 | Ocular icterus | Canada Vigilance: 1 | Canada Vigilance | |
| 1211 | Oral infection | OFFSIDES | ||
| 1212 | Oral torus | OFFSIDES | ||
| 1213 | Oropharyngeal blistering | OFFSIDES | ||
| 1214 | Orthopnea | OFFSIDES | ||
| 1215 | Osteomyelitis | OFFSIDES | ||
| 1216 | Osteoporosis, Postmenopausal | 11991445 | CTD | |
| 1217 | Otitis Media | SIDER | ||
| 1218 | Ovarian Cysts | 17532555 21239663 | CTD | |
| 1219 | Ovarian Diseases | 7496094 16760418 | CTD | |
| 1220 | Ovarian Hyperstimulation Syndrome | 11719720 12960445 | CTD | |
| 1221 | Parkinson Disease | 10408542 | CTD | |
| 1222 | Parotitis | OFFSIDES | ||
| 1223 | Pelvic prolapse | OFFSIDES | ||
| 1224 | Pelvic venous thrombosis | SIDER | ||
| 1225 | Periarthritis | OFFSIDES | ||
| 1226 | Perineal pain | Canada Vigilance: 2 | Canada Vigilance SIDER | |
| 1227 | Peroneal nerve injury | OFFSIDES | ||
| 1228 | Pharyngeal swelling | Canada Vigilance: 3 | Canada Vigilance | |
| 1229 | Phlebitis | Canada Vigilance: 2 | Canada Vigilance SIDER | |
| 1230 | Pinguecula | OFFSIDES | ||
| 1231 | Pituitary Neoplasms |
170818
1411134 1534540 1740019 2082122 2403391 2924731 3104256 3613869 3991064 6477585 6588219 6675538 6697959 6743839 7670571 9214597 10569801 12897383 17283240 28616971 | CTD | |
| 1232 | Platybasia | OFFSIDES | ||
| 1233 | Pleural Infection | SIDER | ||
| 1234 | Polycystic Ovary Syndrome | 29055809 | CTD | |
| 1235 | Polymyalgia Rheumatica | OFFSIDES | ||
| 1236 | Polyneuropathy | OFFSIDES | ||
| 1237 | Porphyria Cutanea Tarda | SIDER | ||
| 1238 | Porphyria non-acute | SIDER | ||
| 1239 | Post procedural cellulitis | OFFSIDES | ||
| 1240 | Posterior Capsulotomy | OFFSIDES | ||
| 1241 | Postmenopausal bleeding | OFFSIDES | ||
| 1242 | Postmenopause | OFFSIDES | ||
| 1243 | Postoperative ileus | OFFSIDES | ||
| 1244 | Postoperative infection | OFFSIDES | ||
| 1245 | Postoperative wound complication | OFFSIDES | ||
| 1246 | Pouchitis | OFFSIDES | ||
| 1247 | Pre-Eclampsia | 19903522 | CTD | |
| 1248 | Precancerous Conditions | 8335407 | CTD | |
| 1249 | Precancerous skin lesion | OFFSIDES | ||
| 1250 | Prenatal Exposure Delayed Effects | CTD | ||
| 1251 | Prenatal Injuries | 12507662 23557687 | CTD | |
| 1252 | Procedural site reaction | OFFSIDES | ||
| 1253 | Product compounding quality issue | Canada Vigilance: 1 | Canada Vigilance | |
| 1254 | Productive Cough | OFFSIDES | ||
| 1255 | Progesterone receptor assay | OFFSIDES | ||
| 1256 | Prostatic Diseases | 4057428 | CTD | |
| 1257 | Prostatic Hyperplasia | 30387366 | CTD | |
| 1258 | Prostatic Neoplasms | CTD | ||
| 1259 | Prurigo | SIDER | ||
| 1260 | Pulse irregular | SIDER | ||
| 1261 | Pyelonephritis | 385009 | CTD OFFSIDES | |
| 1262 | Pyloric Stenosis | Canada Vigilance: 1 | Canada Vigilance | |
| 1263 | Rales | OFFSIDES | ||
| 1264 | Rebound effect | Canada Vigilance: 1 | Canada Vigilance | |
| 1265 | Rectal polyp | OFFSIDES | ||
| 1266 | Rectocele | OFFSIDES | ||
| 1267 | Redness | SIDER | ||
| 1268 | Relapsing Fever | OFFSIDES | ||
| 1269 | Respiratory Hypersensitivity | 30445053 | CTD | |
| 1270 | Retinal Artery Occlusion | OFFSIDES | ||
| 1271 | Retinal pigmentation | OFFSIDES | ||
| 1272 | Rhabdomyosarcoma | 1219538 | CTD | |
| 1273 | Rheumatic Fever | OFFSIDES | ||
| 1274 | Rheumatoid Nodule | OFFSIDES | ||
| 1275 | Rhinitis | Canada Vigilance: 1 | Canada Vigilance SIDER | |
| 1276 | Sarcoma | Canada Vigilance: 1 | Canada Vigilance | |
| 1277 | Scan lymph nodes | OFFSIDES | ||
| 1278 | Seizures | 9761326 18760902 | CTD | |
| 1279 | Seronegative arthritis | OFFSIDES | ||
| 1280 | Serositis | OFFSIDES | ||
| 1281 | Serum Sickness | Canada Vigilance: 1 | Canada Vigilance | |
| 1282 | Shock | SIDER | ||
| 1283 | Sick Sinus Syndrome | OFFSIDES | ||
| 1284 | Sinus Thrombosis, Intracranial | 8638876 | CTD | |
| 1285 | Sinus antrostomy | OFFSIDES | ||
| 1286 | Skin necrosis | OFFSIDES | ||
| 1287 | Skin tenderness | SIDER | ||
| 1288 | Sleep Initiation and Maintenance Disorders | 10340283 | CTD | |
| 1289 | Sleep Talking | OFFSIDES | ||
| 1290 | Sleep-related eating disorder | OFFSIDES | ||
| 1291 | Slurred speech | SIDER | ||
| 1292 | Snoring | Canada Vigilance: 1 | Canada Vigilance | |
| 1293 | Spinal column stenosis | OFFSIDES | ||
| 1294 | Spinal haemangioma | OFFSIDES | ||
| 1295 | Splinter | OFFSIDES | ||
| 1296 | Spondylolysis | OFFSIDES | ||
| 1297 | Sunburn | Canada Vigilance: 1 | Canada Vigilance SIDER | |
| 1298 | Synovial Cyst | OFFSIDES | ||
| 1299 | Tachycardia, Ventricular | 11907179 | CTD | |
| 1300 | Temporal Arteritis | OFFSIDES | ||
| 1301 | Tendinitis | OFFSIDES | ||
| 1302 | Tenosynovitis | OFFSIDES | ||
| 1303 | Tension Headache | SIDER | ||
| 1304 | Testicular Diseases | 31352104 | CTD | |
| 1305 | Thirst | Canada Vigilance: 2 | Canada Vigilance | |
| 1306 | Thromboembolism | SIDER | ||
| 1307 | Tibial Fractures | 19048282 | CTD | |
| 1308 | Tinea Pedis | OFFSIDES | ||
| 1309 | Tongue blistering | OFFSIDES | ||
| 1310 | Tonsillectomy | OFFSIDES | ||
| 1311 | Torsades de Pointes | 10355701 | CTD | |
| 1312 | Toxic reaction (NOS) | SIDER | ||
| 1313 | Toxoplasmosis | OFFSIDES | ||
| 1314 | Tracheobronchitis | OFFSIDES | ||
| 1315 | Troponin increased | OFFSIDES | ||
| 1316 | Ulcer | SIDER | ||
| 1317 | Upset stomach | SIDER | ||
| 1318 | Urination Disorders | 1512859 | CTD | |
| 1319 | Urogenital Abnormalities | 4057428 | CTD | |
| 1320 | Uterine Neoplasms | 10667565 | CTD | |
| 1321 | Uterine atrophy | OFFSIDES | ||
| 1322 | Uterine hemorrhage | 11991445 | CTD | |
| 1323 | Vaginal Diseases | 10340283 | CTD | |
| 1324 | Vaginal discomfort | SIDER | ||
| 1325 | Vaginal irritation | SIDER | ||
| 1326 | Vaginitis ulcerative | SIDER | ||
| 1327 | Vasculitis | Canada Vigilance: 2 | Canada Vigilance | |
| 1328 | Vasodilation procedure | SIDER | ||
| 1329 | Vasodilation | SIDER | ||
| 1330 | Vasospasm, Intracranial | 17053178 18950269 | CTD | |
| 1331 | Ventricular Dysfunction, Left | 21670166 | CTD | |
| 1332 | Ventricular Fibrillation | 11907179 | CTD | |
| 1333 | Viral pharyngitis | OFFSIDES | ||
| 1334 | Viral upper respiratory tract infection | OFFSIDES | ||
| 1335 | Vitamin A Deficiency | OFFSIDES | ||
| 1336 | Vitamin B 12 Deficiency | OFFSIDES | ||
| 1337 | Vitrectomy | OFFSIDES | ||
| 1338 | Vulvitis | Canada Vigilance: 2 | Canada Vigilance | |
| 1339 | Weight Gain | 11991445 25859628 31352104 | CTD OFFSIDES | |
| 1340 | Wound abscess | OFFSIDES | ||
| 1341 | Xerophthalmia | Canada Vigilance: 2 | Canada Vigilance | |
| 1342 | colonoscopy | OFFSIDES | ||
| 1343 | kyphosis | OFFSIDES | ||
| 1344 | muscle injury | OFFSIDES | ||
| 1345 | prostatitis | 10613394 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.